US20070166496A1 - Method and apparatus for thermal spray processing of medical devices - Google Patents
Method and apparatus for thermal spray processing of medical devices Download PDFInfo
- Publication number
- US20070166496A1 US20070166496A1 US11/724,766 US72476607A US2007166496A1 US 20070166496 A1 US20070166496 A1 US 20070166496A1 US 72476607 A US72476607 A US 72476607A US 2007166496 A1 US2007166496 A1 US 2007166496A1
- Authority
- US
- United States
- Prior art keywords
- stent
- coating
- spray
- grains
- processing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/30—Inorganic materials
- A61L27/306—Other specific inorganic materials not covered by A61L27/303 - A61L27/32
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/34—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/08—Materials for coatings
- A61L29/085—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/08—Materials for coatings
- A61L29/10—Inorganic materials
- A61L29/106—Inorganic materials other than carbon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
- A61L29/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
- A61L31/082—Inorganic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
- A61L31/082—Inorganic materials
- A61L31/088—Other specific inorganic materials not covered by A61L31/084 or A61L31/086
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
- A61L31/10—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/146—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- C—CHEMISTRY; METALLURGY
- C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
- C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
- C23C24/00—Coating starting from inorganic powder
- C23C24/02—Coating starting from inorganic powder by application of pressure only
- C23C24/04—Impact or kinetic deposition of particles
-
- C—CHEMISTRY; METALLURGY
- C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
- C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
- C23C28/00—Coating for obtaining at least two superposed coatings either by methods not provided for in a single one of groups C23C2/00 - C23C26/00 or by combinations of methods provided for in subclasses C23C and C25C or C25D
-
- C—CHEMISTRY; METALLURGY
- C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
- C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
- C23C28/00—Coating for obtaining at least two superposed coatings either by methods not provided for in a single one of groups C23C2/00 - C23C26/00 or by combinations of methods provided for in subclasses C23C and C25C or C25D
- C23C28/02—Coating for obtaining at least two superposed coatings either by methods not provided for in a single one of groups C23C2/00 - C23C26/00 or by combinations of methods provided for in subclasses C23C and C25C or C25D only coatings only including layers of metallic material
- C23C28/028—Including graded layers in composition or in physical properties, e.g. density, porosity, grain size
-
- C—CHEMISTRY; METALLURGY
- C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
- C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
- C23C28/00—Coating for obtaining at least two superposed coatings either by methods not provided for in a single one of groups C23C2/00 - C23C26/00 or by combinations of methods provided for in subclasses C23C and C25C or C25D
- C23C28/30—Coatings combining at least one metallic layer and at least one inorganic non-metallic layer
- C23C28/32—Coatings combining at least one metallic layer and at least one inorganic non-metallic layer including at least one pure metallic layer
- C23C28/321—Coatings combining at least one metallic layer and at least one inorganic non-metallic layer including at least one pure metallic layer with at least one metal alloy layer
-
- C—CHEMISTRY; METALLURGY
- C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
- C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
- C23C28/00—Coating for obtaining at least two superposed coatings either by methods not provided for in a single one of groups C23C2/00 - C23C26/00 or by combinations of methods provided for in subclasses C23C and C25C or C25D
- C23C28/30—Coatings combining at least one metallic layer and at least one inorganic non-metallic layer
- C23C28/32—Coatings combining at least one metallic layer and at least one inorganic non-metallic layer including at least one pure metallic layer
- C23C28/322—Coatings combining at least one metallic layer and at least one inorganic non-metallic layer including at least one pure metallic layer only coatings of metal elements only
-
- C—CHEMISTRY; METALLURGY
- C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
- C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
- C23C28/00—Coating for obtaining at least two superposed coatings either by methods not provided for in a single one of groups C23C2/00 - C23C26/00 or by combinations of methods provided for in subclasses C23C and C25C or C25D
- C23C28/30—Coatings combining at least one metallic layer and at least one inorganic non-metallic layer
- C23C28/34—Coatings combining at least one metallic layer and at least one inorganic non-metallic layer including at least one inorganic non-metallic material layer, e.g. metal carbide, nitride, boride, silicide layer and their mixtures, enamels, phosphates and sulphates
-
- C—CHEMISTRY; METALLURGY
- C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
- C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
- C23C28/00—Coating for obtaining at least two superposed coatings either by methods not provided for in a single one of groups C23C2/00 - C23C26/00 or by combinations of methods provided for in subclasses C23C and C25C or C25D
- C23C28/30—Coatings combining at least one metallic layer and at least one inorganic non-metallic layer
- C23C28/34—Coatings combining at least one metallic layer and at least one inorganic non-metallic layer including at least one inorganic non-metallic material layer, e.g. metal carbide, nitride, boride, silicide layer and their mixtures, enamels, phosphates and sulphates
- C23C28/345—Coatings combining at least one metallic layer and at least one inorganic non-metallic layer including at least one inorganic non-metallic material layer, e.g. metal carbide, nitride, boride, silicide layer and their mixtures, enamels, phosphates and sulphates with at least one oxide layer
- C23C28/3455—Coatings combining at least one metallic layer and at least one inorganic non-metallic layer including at least one inorganic non-metallic material layer, e.g. metal carbide, nitride, boride, silicide layer and their mixtures, enamels, phosphates and sulphates with at least one oxide layer with a refractory ceramic layer, e.g. refractory metal oxide, ZrO2, rare earth oxides or a thermal barrier system comprising at least one refractory oxide layer
-
- C—CHEMISTRY; METALLURGY
- C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
- C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
- C23C28/00—Coating for obtaining at least two superposed coatings either by methods not provided for in a single one of groups C23C2/00 - C23C26/00 or by combinations of methods provided for in subclasses C23C and C25C or C25D
- C23C28/30—Coatings combining at least one metallic layer and at least one inorganic non-metallic layer
- C23C28/36—Coatings combining at least one metallic layer and at least one inorganic non-metallic layer including layers graded in composition or physical properties
-
- C—CHEMISTRY; METALLURGY
- C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
- C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
- C23C4/00—Coating by spraying the coating material in the molten state, e.g. by flame, plasma or electric discharge
- C23C4/12—Coating by spraying the coating material in the molten state, e.g. by flame, plasma or electric discharge characterised by the method of spraying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/42—Anti-thrombotic agents, anticoagulants, anti-platelet agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/606—Coatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2420/00—Materials or methods for coatings medical devices
- A61L2420/02—Methods for coating medical devices
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
- B05B7/00—Spraying apparatus for discharge of liquids or other fluent materials from two or more sources, e.g. of liquid and air, of powder and gas
- B05B7/0006—Spraying by means of explosions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
- B05B7/00—Spraying apparatus for discharge of liquids or other fluent materials from two or more sources, e.g. of liquid and air, of powder and gas
- B05B7/16—Spraying apparatus for discharge of liquids or other fluent materials from two or more sources, e.g. of liquid and air, of powder and gas incorporating means for heating or cooling the material to be sprayed
- B05B7/20—Spraying apparatus for discharge of liquids or other fluent materials from two or more sources, e.g. of liquid and air, of powder and gas incorporating means for heating or cooling the material to be sprayed by flame or combustion
- B05B7/201—Spraying apparatus for discharge of liquids or other fluent materials from two or more sources, e.g. of liquid and air, of powder and gas incorporating means for heating or cooling the material to be sprayed by flame or combustion downstream of the nozzle
- B05B7/203—Spraying apparatus for discharge of liquids or other fluent materials from two or more sources, e.g. of liquid and air, of powder and gas incorporating means for heating or cooling the material to be sprayed by flame or combustion downstream of the nozzle the material to be sprayed having originally the shape of a wire, rod or the like
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
- B05B7/00—Spraying apparatus for discharge of liquids or other fluent materials from two or more sources, e.g. of liquid and air, of powder and gas
- B05B7/16—Spraying apparatus for discharge of liquids or other fluent materials from two or more sources, e.g. of liquid and air, of powder and gas incorporating means for heating or cooling the material to be sprayed
- B05B7/20—Spraying apparatus for discharge of liquids or other fluent materials from two or more sources, e.g. of liquid and air, of powder and gas incorporating means for heating or cooling the material to be sprayed by flame or combustion
- B05B7/201—Spraying apparatus for discharge of liquids or other fluent materials from two or more sources, e.g. of liquid and air, of powder and gas incorporating means for heating or cooling the material to be sprayed by flame or combustion downstream of the nozzle
- B05B7/205—Spraying apparatus for discharge of liquids or other fluent materials from two or more sources, e.g. of liquid and air, of powder and gas incorporating means for heating or cooling the material to be sprayed by flame or combustion downstream of the nozzle the material to be sprayed being originally a particulate material
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
- B05B7/00—Spraying apparatus for discharge of liquids or other fluent materials from two or more sources, e.g. of liquid and air, of powder and gas
- B05B7/16—Spraying apparatus for discharge of liquids or other fluent materials from two or more sources, e.g. of liquid and air, of powder and gas incorporating means for heating or cooling the material to be sprayed
- B05B7/22—Spraying apparatus for discharge of liquids or other fluent materials from two or more sources, e.g. of liquid and air, of powder and gas incorporating means for heating or cooling the material to be sprayed electrically, magnetically or electromagnetically, e.g. by arc
- B05B7/222—Spraying apparatus for discharge of liquids or other fluent materials from two or more sources, e.g. of liquid and air, of powder and gas incorporating means for heating or cooling the material to be sprayed electrically, magnetically or electromagnetically, e.g. by arc using an arc
- B05B7/224—Spraying apparatus for discharge of liquids or other fluent materials from two or more sources, e.g. of liquid and air, of powder and gas incorporating means for heating or cooling the material to be sprayed electrically, magnetically or electromagnetically, e.g. by arc using an arc the material having originally the shape of a wire, rod or the like
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
- B05B7/00—Spraying apparatus for discharge of liquids or other fluent materials from two or more sources, e.g. of liquid and air, of powder and gas
- B05B7/16—Spraying apparatus for discharge of liquids or other fluent materials from two or more sources, e.g. of liquid and air, of powder and gas incorporating means for heating or cooling the material to be sprayed
- B05B7/22—Spraying apparatus for discharge of liquids or other fluent materials from two or more sources, e.g. of liquid and air, of powder and gas incorporating means for heating or cooling the material to be sprayed electrically, magnetically or electromagnetically, e.g. by arc
- B05B7/222—Spraying apparatus for discharge of liquids or other fluent materials from two or more sources, e.g. of liquid and air, of powder and gas incorporating means for heating or cooling the material to be sprayed electrically, magnetically or electromagnetically, e.g. by arc using an arc
- B05B7/226—Spraying apparatus for discharge of liquids or other fluent materials from two or more sources, e.g. of liquid and air, of powder and gas incorporating means for heating or cooling the material to be sprayed electrically, magnetically or electromagnetically, e.g. by arc using an arc the material being originally a particulate material
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/12—All metal or with adjacent metals
- Y10T428/12014—All metal or with adjacent metals having metal particles
- Y10T428/12021—All metal or with adjacent metals having metal particles having composition or density gradient or differential porosity
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/12—All metal or with adjacent metals
- Y10T428/12292—Workpiece with longitudinal passageway or stopweld material [e.g., for tubular stock, etc.]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/12—All metal or with adjacent metals
- Y10T428/12299—Workpiece mimicking finished stock having nonrectangular or noncircular cross section
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/13—Hollow or container type article [e.g., tube, vase, etc.]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/13—Hollow or container type article [e.g., tube, vase, etc.]
- Y10T428/1352—Polymer or resin containing [i.e., natural or synthetic]
- Y10T428/1376—Foam or porous material containing
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/13—Hollow or container type article [e.g., tube, vase, etc.]
- Y10T428/1352—Polymer or resin containing [i.e., natural or synthetic]
- Y10T428/139—Open-ended, self-supporting conduit, cylinder, or tube-type article
Definitions
- This invention relates to medical devices and more particularly, the invention relates to methods of manufacturing and coating medical devices utilizing thermal spray processing (TSP).
- TSP thermal spray processing
- a guiding catheter having a distal tip is percutaneously introduced through the femoral artery into the cardiovascular system of a patient using a conventional Seldinger technique and advanced within the cardiovascular system until the distal tip of the guiding catheter is seated at the ostium of the coronary arteries.
- a guide wire is positioned within an inner lumen of a dilatation catheter and then both are advanced through the guiding catheter to the distal end thereof.
- the guide wire is first advanced out of the distal end of the guiding catheter into the patient's coronary vasculature until the distal end of the guide wire crosses a lesion to be dilated, then the dilatation catheter having an inflatable balloon on the distal portion thereof is advanced into the patient's coronary anatomy over the previously introduced guide wire until the balloon of the dilatation catheter is properly positioned across the lesion.
- the balloon is inflated to compress the plaque of the lesion against the inside of the artery wall and to otherwise expand the inner lumen of the artery.
- the balloon is then deflated so that blood flow can be resumed through the dilated artery and the dilatation catheter can be removed therefrom.
- Further details of dilatation catheters, guide wires, and devices associated therewith for angioplasty procedures can be found in U.S. Pat. No. 4,323,071 (Simpson-Robert); U.S. Pat. No. 4,439,185 (Lindquist); U.S. Pat. No. 4,516,972 (Samson); U.S. Pat. No.
- Stents are generally cylindrically shaped intravascular devices which are placed within an artery to hold it open. The device can be used to reduce the likelihood of restenosis and to maintain the patency of a blood vessel immediately after intravascular treatments. In some circumstances, they can also be used as the primary treatment device where they are expanded to dilate a stenosis and then left in place. Further details of stents can be found in U.S. Pat. No. 3,868,956 (Alfidi et al.); U.S. Pat. No. 4,512,338 (Balko et al.); U.S. Pat. No.
- One method and system developed for delivering stents to desired locations within the patient's body lumen involves crimping a stent about an expandable member, such as a balloon on the distal end of a catheter, advancing the catheter through the patient's vascular system until the stent is in the desired location within a blood vessel, and then inflating the expandable member on the catheter to expand the stent within the blood vessel. The expandable member is then deflated and the catheter withdrawn, leaving the expanded stent within the blood vessel, holding open the passageway thereof.
- an expandable member such as a balloon on the distal end of a catheter
- 316L stainless steel tubing contains average grain sizes ranging from approximately 0.0025 inch (64 microns), ASTM grain size 5 to around 0.00088 inch (22 microns), ASTM grain size 8. These grain sizes result in anywhere from two to five grains across the tube thickness, and the stent subsequently manufactured from the tubing depending on the tube and stent strut thicknesses. Part of the limitation in achieving a finer grain size in this material arises from the number of draws and anneals the tubing must go through to achieve its final size. The potential for reducing the grain size exists by reducing the required number of heat-processing steps by reducing the starting size of the raw product that is then processed down into the tubing.
- the present invention relates to methods of manufacturing and coating medical devices utilizing thermal spray processing (TSP).
- TSP thermal spray processing
- the process includes producing a coating having an average grain size of between 1 and 64 microns and providing a thin walled structure having a wall thickness of about eight or more grains. While the grain size for thin walled structures (such as stents) has been referred to herein as about eight or more grains, the number of grains does vary depending on wall thickness. Thus, for very thin walled structures the wall thickness may be between four and eight grains, but for most (but not all) stent applications it is desirable to have at least eight or more grains comprising the wall thickness.
- the invention involves the use of TSP for the manufacture of fine grained tubing for subsequent use as a medical device such as a stent or other tubular or ring-based implant, the manufacture of intermediate size tube that may then be drawn into final size tubing, and for the coating of a stent or other medical device.
- Medical devices which will benefit from the present invention include stents, guide wires, ring markers, tubular or wire based implants, defibrillator lead tips, and catheters and other delivery system devices. While the present invention TSP is utilized for the medical devices described herein, stents will be used as an example of the inventive manufacturing process and coating process disclosed and claimed herein.
- Thermal spray is a generic term for a broad class of related processes in which molten droplets of metals, ceramics, glasses, and/or polymers are sprayed onto a surface to produce a coating, to form a free-standing near-net-shape, or to create an engineered material with unique properties (e.g., strain-tolerant ceramics, metallic glasses, cermets, or metal/polymer composites).
- any material with a stable molten phase can be thermally sprayed, and a wide range of pure and composite materials are routinely sprayed for both research and industrial applications.
- Deposition rates are very high in comparison to alternative coating technologies.
- Deposit thicknesses of 0.1 to 1 mm are common, and thicknesses greater than 1 cm can be achieved with some materials.
- the invention relates to the overall manufacturing of tube stock and coatings, creating layered material and other materials through powder consolidation during spraying, with the additional potential of creating composite materials.
- 316L stainless steel tubing contains average grain sizes ranging from approximately 0.0025 inch (64 microns), ASTM grain size 5 to around 0.00088 inch (22 microns), ASTM grain size 8. These grain sizes result in anywhere from two to five grains across the tube thickness, and the stent subsequently manufactured from this tubing depending on the tube and stent strut thicknesses. Part of the limitation in achieving a finer grain size in this material arises from the number of draws and anneals the tubing must go through to achieve its final size. The potential for reducing the grain size exists by reducing the required number of heat-processing steps by reducing the starting size of the raw product that is then processed down into the tubing.
- the grain size and increasing the number of grains across the strut thickness allows the grains within the stent to act more as a continuum and less as a step function.
- the result of processing the material to a smaller grain size in a stent would result in an average grain size of between approximately 1 and 64 microns, with a subsequent average number of grains across the strut thickness about eight or greater.
- the average number of grains in a cross-section of a medical device depends upon the size of the device and the diameter of the grains.
- the manufacturing process includes thermal spray processing.
- Thermal spray processing can be generally defined as a group of processes in which finely divided metallic or nonmetallic surfacing materials are deposited in a molten or semi-molten condition on a substrate to form a spray deposit.
- Cold spray thermal processing to be discussed herein, is considered a thermal spray process although the materials projected onto a surface are not necessarily molten or semi-molten.
- TSP includes several variants such as cold spraying, combustion spraying, arc spraying, high velocity oxy-fuel spraying, and plasma spraying.
- sprayed materials include elements, metallic alloys, ceramics, composites and polymers.
- TSP can be considered to be a net or near net shaped process.
- the product that comes out of the thermal spray process is close to or at the desired size and shape of the final product.
- This process can be used not only to coat a stent but also to manufacture tube stock that is used in place of gun drilled or extruded rod or subsequent tube manufacturing.
- Some factors to consider when spray forming include the grain size, porosity, and dimensional tolerances of the sprayed part.
- Post-processing can assist when one or more of these factors is not as desired for the final product.
- TSP processing is presented here both with and without post-processing of the material.
- thermal processing Some advantages include the versatility with respect to feed materials (metals, ceramics, and polymers in the form of wires, rods, or powders); the capacity to form barrier and functional coatings on a wide range of substrates; the ability to create freestanding structures for net-shape manufacturing of high-performance ceramics, composites, and functionally graded materials; and the rapid-solidification synthesis of specialized materials.
- TSP may be used to spray-form tube stock on top of a removable mandrel.
- the thickness of the tube may be varied by spraying more or less material, and the inner diameter dimensions may be varied by changing the size of the mandrel.
- the inner mandrel may be made of a substance that melts out or that is coated with a substance that allows easy removal of the finished sprayed tube. If the grain size, porosity, and dimensional tolerances (including wall runout, wall thickness, concentricity and surface roughness) are as desired, the mandrel may be removed and the sprayed tube is ready for further processing into a stent or other tubular or ring-shaped product. To create a ring-shaped product from a tube product, the tube is sprayed to the desired dimensions and then sliced in the transverse direction to result in rings of the desired size.
- Grain size of the finished tube depends on numerous factors, including the size of the particles being sprayed, the formation, impact and rate of solidification of the sprayed material, and the length of time the material is heated above a temperature that allows significant grain growth.
- the tube may be swaged to introduce heavy dislocation densities, then heat treated to recrystallize the material into finer grains.
- different material forms may be taken through a drawing or other working and heat treat processes to recrystallize the tubing. The type and amount of working allowed depends on the material, e.g., ceramics may require a high temperature working step while metals and composites may be workable at room temperature.
- Grain-size strengthening is where there is an increase in strength of a material due to a decrease in the grain size.
- the larger grain-boundary area more effectively blocks dislocation movement.
- the outer diameter of the tube usually requires a machining step of some sort to smooth the surface after the swaging process, and the same may be true before the tubing can be properly drawn.
- the sprayed material may contain porosity, or small voids. These may be minimized or eliminated through control of the TSP parameters.
- One potential method of post processing involves a traveling ring furnace, where the material is melted and re-solidified as the ring travels down the length of the tube. This method requires close control to prevent preferential segregation of elements along with the melt pool.
- Another method is to process the material under high mechanical pressure to sinter the grains together; this method is generally used for powder processing. As porosity is difficult to remove from a material, however, the best form of elimination is to ensure that the TSP parameters are such that the porosity is not present in the first place.
- TSP is a near-net shape process
- variability in the process itself may require post-processing so that the product achieves the required dimensional tolerances.
- Such processing may include machining of some form or centerless grinding the outer diameter oft he sprayed tube to reduce wall thickness variability and to improve the surface finish.
- the inner diameter dimensions and surface finish should be dependant on the mandrel that it is sprayed on. If the starting size of the sprayed tube is large enough, it may be desirous to bore and ream or just ream the inner diameter for both dimension and surface roughness improvement.
- An alternate method is to perform a drawing operation on the TSP tube to draw the tube to the desired final size. In this case, if the outer diameter is too rough, the tube will need to be machined or ground prior to the drawing operation.
- TSP may be used to coat an object with a desired material.
- the thickness of the coating may be varied by spraying more or less material, and this thickness may be varied along the length and around the diameter of the product.
- the advantage of using TSP as a coating process is the wide variety of materials that may be sprayed, including metallic elements, known and novel metallic alloys, ceramics, composites and polymers.
- Grain or node size, material density or porosity, and final dimensions will be considered here as the parameters for performing post-processing.
- Grain size or node size of the finished coating will depend on numerous factors, including the size oft he particles being sprayed, the formation, impact and rate of solidification of the sprayed material, and the length of time the material is heated above a temperature that allows significant grain growth.
- a metallic coating For a metallic coating, one modification to grain size that may be made is to heat treat the coating and grow the grains. It is generally difficult to work the stent and coating material in a way that introduces a high dislocation density that may then be used to recrystallize the material.
- the wire For a metallic wire coating, the wire may be swaged or drawn to produce a higher dislocation density, then annealed to recrystallize to a smaller grain size; the same may be true of a tube that is coated.
- heating may be a post-processing step, while for a polymeric coating, further cross-linking may be necessary.
- the sprayed material may contain porosity, or small voids. These may be minimized or eliminated through control of the TSP parameters.
- One potential method of post processing a metallic, ceramic or composite coating involves a traveling ring furnace where the material is melted and re-solidified as the ring travels down the length of the part. This method requires close control to prevent preferential segregation of elements along with the melt pool as well as to prevent unwanted migration of the coating into the underlying material.
- Another method would be to process the material under high mechanical pressure in a vacuum to sinter the grains together. This method is generally used for powder processing. As porosity is difficult to remove from a material if “no porosity” is a coating requirement, the best form of elimination would be to ensure that the TSP parameters are such that the porosity is not present in the first place.
- TSP is a near-net shape process
- variability in the process itself may require post-processing to finalize the coating to required dimensional tolerances.
- Mechanical post-processing of a stent would be difficult because of the diminutive nature of the stent.
- Post-processing of a wire or tubular product is less difficult.
- outer diameter processing may include machining, e.g., centerless grinding, or drawing to reduce coating thickness variability and to improve the surface finish. If a part is sprayed on the inner diameter, it may be desirous to machine out the inner diameter by, for example, boring and/or reaming, for both dimension and surface roughness improvement.
- thermal spray processing includes several variants such as cold spraying, combustion spraying, arc spraying, high velocity oxy-fuel spraying, and plasma spraying.
- TSP thermal spray processing
- cold spray thermal processing generally powder particles are introduced into a high pressure gas where both the gas and particles enter a supersonic jet.
- the jet stream is directed against a mandrel in order to coat the mandrel with particles and form either tube stock or a coating.
- the cold spray process involves minimal heat input to the feedstock powder or the substrate thus making it possible to deposit thermally sensitive as well as conventional materials.
- the process generally produces high density, low residual stress deposits with low oxide contents.
- the combustion wire thermal spray process is basically the spraying of molten metal onto a surface to provide tube stock or a coating.
- Material in wire form is melted in a flame (oxy-acetylene flame is the most common) and atomized using compressed air to form a fine spray.
- a flame oxygen-acetylene flame is the most common
- compressed air compressed air
- the combustion powder thermal spray process is also basically the spraying of molten material onto a surface to provide tube stock or a coating.
- material in powder form is melted in a flame (oxy-acetylene or hydrogen is the most common) to form a fine spray.
- a flame oxygen-acetylene or hydrogen is the most common
- the fine molten droplets rapidly solidify forming tube stock or a coating.
- This process carried out correctly is called a “cold process” (relative to the substrate material being coated) as the substrate temperature can be kept low during processing thus avoiding damage, metallurgical changes and distortion to the substrate material.
- arc spray substrates and coatings include high bond strength and density, low internal stresses, high thickness capability, and high quality microstructures.
- the hvof (high velocity oxygen fuel) thermal spray process is similar to the combustion powder spray process except that hvof has been developed to produce extremely high spray velocity.
- Several hvof guns use different methods to achieve high velocity spraying.
- One method is basically a high pressure water cooled combustion chamber and long nozzle. Fuel (kerosene, acetylene, propylene and hydrogen) and oxygen are fed into the chamber, combustion produces a hot high pressure flame which is forced down a nozzle increasing its velocity. Powder may be fed axially into the combustion chamber under high pressure or fed through the side of laval type nozzle where the pressure is lower.
- Another method uses a simpler system of a high pressure combustion nozzle and air cap.
- Fuel gas propane, propylene or hydrogen
- oxygen are supplied at high pressure, combustion occurs outside the nozzle but within an air cap supplied with compressed air.
- the compressed air pinches and accelerates the flame and acts as a coolant for the gun.
- Powder is fed at high pressure axially from the center of the nozzle. Benefits include high particle velocity, low particle temperatures, and time at temperature during the spraying process, which reduces oxidation and degradation of constituents.
- the plasma spray process is basically the spraying of molten or heat softened material onto a surface to provide tube stock or a coating.
- Material in the form of powder is injected into a very high temperature plasma flame, where it is rapidly heated and accelerated to a high velocity.
- the hot material impacts on the substrate surface and rapidly cools forming tube stock or a coating.
- This process carried out correctly is called a “cold process” (relative to the substrate material being coated) as the substrate temperature can be kept low during processing thus avoiding damage, metallurgical changes and distortion to the substrate material.
- the plasma gun comprises a copper anode and tungsten cathode, both of which are water cooled.
- Plasma gas argon, nitrogen, hydrogen, helium
- the plasma is initiated by a high voltage discharge which causes localized ionization and a conductive path for a DC arc to form between cathode and anode.
- the resistance heating from the arc causes the gas to reach extreme temperatures, dissociate and ionize to form a plasma.
- the plasma exits the anode nozzle as a free or neutral plasma flame (plasma which does not carry electric current).
- the electric arc extends down the nozzle, instead of shorting out to the nearest edge of the anode nozzle.
- This stretching of the arc is due to a thermal pinch effect.
- Powder is fed into the plasma flame most commonly via an external powder port mounted near the anode nozzle exit. The powder is so rapidly heated and accelerated that spray distances can be on the order of 25 to 150 mm.
- Benefits associated with plasma spray include a high degree of flexibility, the largest choice of substrate and coating materials, and high production spray rates in which the process can be highly automated.
- the detonation gun basically consists of a long water cooled barrel with inlet valves for gases and powder. Oxygen and fuel (acetylene is the most common) is fed into the barrel along with a charge of powder. A spark is used to ignite the gas mixture and the resulting detonation heats and accelerates the powder to supersonic velocity down the barrel. A pulse of nitrogen is used to purge the barrel after each detonation. This process is repeated many times a second. The high kinetic energy of the hot powder particles on impact with the substrate result in a build up of a very dense and strong tube stock or coating.
- Oxygen and fuel acetylene is the most common
- TSP processes provide a tubing product that can be formed into a stent that has strut cross-sections having an average grain size of less than or equal to 10 microns or an average thickness of about eight or more grains depending on the strut thickness.
- the disclosed processes also are applicable to the medical devices described herein.
- FIG. 1 is an elevational view, partially in section, of a stent embodying features of the invention which is mounted on a delivery catheter and disposed within a damaged artery.
- FIG. 2 is an elevational view, partially in section, similar to that shown in FIG. 1 wherein the stent is expanded within an artery.
- FIG. 3 is an elevational view, partially in section showing the expanded stent within the artery after withdrawal of the delivery catheter.
- FIG. 4 is a perspective view of a stent embodying in an unexpanded state, with one end of the stent being shown in an exploded view to illustrate the details thereof.
- FIG. 5 is a plan view of a flattened section of a stent of the invention which illustrates the undulating pattern of the stent shown in FIG. 4 .
- FIG. 5A is a cross-sectional view taken along the line 5 A- 5 A in FIG. 5 .
- FIG. 6 is a schematic diagram of a spherical particle impinged onto a flat substrate (splat).
- FIG. 7 is a schematic diagram of a thermal spray coating.
- FIG. 8 is a schematic diagram of a cold spray thermal spray processing apparatus.
- FIG. 9 is a schematic diagram of a combustion wire thermal spray processing apparatus.
- FIG. 10 is a schematic diagram of a combustion powder thermal spray processing apparatus.
- FIG. 11 is a schematic diagram of an arc wire thermal spray processing apparatus.
- FIG. 12 is a schematic diagram of an hvof thermal spray processing apparatus.
- FIG. 13 is a schematic diagram of a plasma thermal spray processing apparatus.
- FIG. 14 is a schematic diagram of a detonation thermal spray processing apparatus.
- FIG. 15 is a schematic representation of equipment for selectively cutting the tubing in the manufacture of stents, in accordance with the present invention.
- the present invention relates to manufacturing processes for forming a medical device such as tube stock or piece of tubing, a wire, or to provide a coating on a tube for subsequent use as an intravascular stent, a guide wire, a ring marker, defibrillator lead tips, catheters and delivery systems. While virtually any medical device that is implanted or used in the body will benefit from the present invention, the invention as applied to stents is described herein as only an example and is not meant to be limiting. Thus, tube stock or wires made or coated by the process of the present invention might be used for stents, guide wires, catheters, markers, lead tips, and the like.
- Stents are well known in the art and can have many different types of patterns and configurations.
- the following description of an intravascular stent as shown in FIGS. 1-5A is a typical stent pattern made from stainless steel tubing.
- Other patterns are well known in the art and the foregoing description of a stent and delivery system is by way of example, and is not meant to be limiting.
- the stent is a high precision patterned tubular device that typically includes a number of radially expandable cylindrical elements or rings 12 disposed generally coaxially and interconnected by links 13 disposed between adjacent rings.
- the delivery catheter has an expandable portion or balloon 14 for expanding the stent within an artery 15 .
- the typical delivery catheter 11 onto which the stent 10 is mounted is similar in operation to a conventional balloon dilatation catheter for angioplasty procedures. Portions oft he proximal end of such catheters can be made of metal tubing or metal wire.
- the balloon 14 may be formed of suitable materials such as polyethylene, polyethylene terephthalate, polyvinyl chloride, nylon and ionomers such as Surlyn® of the manufactured by the Polymer Products Division oft he Du Pont Company. Other polymers may also be used.
- the stent In order for the stent to remain in place on the balloon during delivery to the site of the damage within the artery 15 , the stent is compressed onto the balloon.
- the delivery of the stent 10 is accomplished in the following manner.
- the stent is first mounted onto the inflatable balloon 14 on the distal extremity of the delivery catheter 11 .
- the catheter-stent assembly is introduced within the patient's vasculature in a conventional Seldinger technique through a guiding catheter (not shown).
- a guide wire 18 is disposed across the damaged arterial section and then the catheter/stent assembly is advanced over the guide wire within the artery until the stent is directly within the target site.
- guide wires also will benefit from the processes oft he present invention.
- the balloon of the catheter is expanded, expanding the stent against the artery, which is illustrated in FIG. 2 .
- the artery is preferably expanded slightly by the expansion of the stent to seat or otherwise fix the stent to prevent movement.
- the artery may have to be expanded considerably in order to facilitate passage of blood or other fluid therethrough.
- the stent 10 serves to hold open the artery 15 after the balloon 14 is deflated and the catheter 11 is withdrawn, as illustrated by FIG. 3 .
- the undulating component of the rings 12 of the stent is relatively flat in transverse cross-section, so that when the stent is expanded, the rings are pressed into the wall of the artery and, as a result, do not interfere with the blood flow through the artery.
- the closely spaced rings at regular intervals provide uniform support for the wall of the artery and, consequently, are well adapted to hold open the artery, as illustrated in FIGS. 2 and 3 .
- FIG. 4 is an enlarged perspective view of the stent 10 shown in FIG. 1 with one end of the stent shown in an exploded view to illustrate in greater detail the placement of links 13 between adjacent radially expandable rings.
- the stent has three links between adjacent radially expandable rings that are approximately 120° apart. Each pair of links on one side of a ring are circumferentially offset 60° from the pair on the other side of the ring. The alternation oft he links results in a stent which is longitudinally flexible in essentially all directions.
- the rings 12 are in the form of a serpentine pattern 30 .
- each ring is connected by links 13 .
- the serpentine pattern is made up of a plurality of U-shaped members 31 , W-shaped members 32 , and Y-shaped members 33 , each having a different radius so that expansion forces are more evenly distributed over the various members.
- Other stent patterns can be formed by utilizing the processes of the present invention and the embodiment illustrated in FIGS. 1-5 are by way of example and are not intended to be limiting.
- the afore described illustrative stent 10 and similar stent structures can be made in many ways.
- the preferred method of making the disclosed stent in this invention is through a process utilizing thermal spray processing.
- the stent diameter is very small, so the tubing from which it is made must necessarily also have a small diameter.
- the stent has an outer diameter on the order of about 0.030 to 0.060 inch in the unexpanded condition, equivalent to the tubing from which the stent is made, and can be expanded to an outer diameter of 0.10 inch or more.
- the wall thickness of the tubing is about 0.0020 to 0.010 inch.
- the process of manufacturing tube stock or a coating in this invention consists of first selecting a thermal spray processing apparatus from the group consisting cold spray, combustion, hvof, arc, and plasma. Material selected from the group consisting of metals, alloys, polymers, ceramics, and cermets is then thermally spray formed onto either a mandrel to form tube stock or a stent to form a coating. Finally, the tube stock or coated stent is removed for further processing.
- Thermal spray deposits are generally composed of cohesively bonded splats as shown in FIGS. 6 and 7 resulting from the impact, spreading, and rapid solidification of a high flux of particles with deformed shapes.
- the physical properties and behavior of the deposit depend on many factors including the cohesive strength among the splats, the size and morphology oft he porosity, and the occurrence of cracks and defects and on the ultrafine-grained microstructure within the splats themselves.
- the cold spray method offers a means for expanding the operational window for coating and forming stents to permit a variety of materials to be deposited with much lower thermal exposure than encountered in the traditional processes.
- the method exploits properties of gas dynamics which permit supersonic gas streams and attendant particle velocities to be obtained.
- the method additionally permits a high degree of spatial control by virtue of the gas nozzle characteristics and generally short standoff distances which can be employed. This results in a uniform structure of the coating or tube stock with the substantially preserved formation of the powder material without phase transformations and hardening, i.e., the coatings applied do not crack, their corrosion resistance, microhardness, and cohesion and adhesion strength are enhanced.
- the process includes producing a coating having an average grain size of between 1 and 64 microns and providing a thin walled structure having a wall thickness of about eight or more grains. While the grain size for thin walled structures (such as stents) has been referred to herein as about eight or more grains, the number of grains does vary depending on wall thickness. Thus, for very thin walled structures the wall thickness may be between four and eight grains, but for most (but not all) stent applications it is desirable to have at least eight or more grains comprising the wall thickness.
- Typical values for tensile adhesion of the cold spray coatings are in the range of 30-801 MPa (4.4-11.6 ksi), with porosities in the range of 1-10 volume percent, deposit thicknesses ranging from 10 microns to 10 millimeters, deposition rates in the range of 0.010 to about 0.080 m 3 per hour, and deposition efficiencies in the range of 50-80%.
- porosity is dependent on the ambient spray environment, powder characteristics (i.e., particle size and size distribution), and thermal-spray parameters (e.g., powder level, gas-flow features, and spray distance).
- the spray environment will have a significant influence on, for example, oxidation of metals, leading to greater porosity.
- One embodiment utilizes cold spray thermal processing to manufacture the tube stock and apply coatings as shown in FIG. 8 .
- particles of a powder of at least one first material are selected from the group including metals, metal alloys, or polymers and mechanical mixture of a metal and an alloy.
- the preferred particle size ranges from about 1 to 64 microns.
- the powder is fed through the powder feeder and then introduced into a gas selected from the group of Nitrogen (N 2 ), Oxygen (O 2 ), Air, Helium (He), Argon (Ar), Xenon (Xe), or Carbon Dioxide (CO 2 ).
- the gas also passes through the heater. Both the gas and particles are then fed into the supersonic nozzle with an inlet temperature between about 380 to 420° Celsius.
- the corresponding inlet velocity ranges from about 300 to about 1,200 m/sec and the inlet pressure is preferred to be between 1.5 to 2.5 Mpa.
- the nozzle is then directed against a mandrel which is placed 8 to 10 mm away.
- the mandrel is thereafter coated with the particles to form the tube stock or coating desired.
- the tube stock or coated stent is removed from the mandrel after it is formed.
- the combustion wire thermal spray process shown in FIG. 9 is basically the spraying of molten particles onto a mandrel to produce tube stock or a coating.
- the wire is propelled and melted into the flame (oxy-acetylene flame most common) and atomized by the compressed air to form a fine spray.
- the fine molten droplets rapidly solidify forming tube stock or a coating.
- This process carried out correctly, is called a “cold process” (relative to the substrate material being coated) as the substrate temperature can be kept low during processing thus avoiding damage, metallurgical changes and distortion to the substrate material.
- the combustion powder thermal spray process shown in FIG. 10 is also basically the spraying of molten material onto a surface to provide tube stock or a coating.
- powder is propelled and melted into the flame (oxy-acetylene or hydrogen most common) to form a fine spray.
- the fine molten droplets rapidly solidify forming tube stock or a coating.
- This process carried out correctly, is also called a “cold process” (relative to the substrate material being coated) as the substrate temperature can be kept low during processing thus avoiding damage, metallurgical changes and distortion to the substrate material.
- a pair of electrically conductive wires are melted by means of an electric arc created between the two.
- the molten material is atomized by the compressed air and propelled towards the substrate surface.
- the impacting molten particles on the substrate rapidly solidify to form tube stock or a coating.
- This process carried out correctly, is called a “cold process” (relative to the substrate material being coated) as the substrate temperature can be kept low during processing thus avoiding damage, metallurgical changes and distortion to the substrate material.
- the hvof (high velocity oxygen fuel) thermal spray process shown in FIG. 12 is similar to the combustion powder spray process except that hvof has been developed to produce extremely high spray velocities.
- the method shown is basically a high pressure water cooled combustion chamber and long nozzle. Fuel (kerosene, acetylene, propylene and hydrogen) and oxygen are fed into the chamber where combustion produces a hot high pressure flame which is forced down a nozzle thereby increasing its velocity.
- the powder may be fed axially into the combustion chamber under high pressure or fed through the side of laval type nozzle where the pressure is lower.
- Another method uses a simpler system of a high pressure combustion nozzle and air cap.
- Fuel gas (propane, propylene or hydrogen) and oxygen are supplied at high pressure, combustion occurs outside the nozzle but within an air cap supplied with compressed air.
- the compressed air pinches and accelerates the flame and acts as a coolant for the gun.
- Powder is fed at high pressure axially from the center of the nozzle.
- the gas and particle velocity exiting an hvof gun can be in excess of 2500 feet per second.
- the velocity of the metallic particles causes friction through kinetic energy when the particles make contact with a substrate. This high energy can aid in the melting and adhesion of the particles to the substrate.
- the gas temperature is usually very high, ranging from 2500° to 4500° F.
- the plasma spray process shown in FIG. 13 is basically the spraying of molten or heat softened material onto a surface to provide tube stock or a coating. Powdered material is directed through the powder injection and into the high temperature plasma flame, where it is rapidly heated and accelerated to a high velocity. The hot material impacts on the substrate surface and rapidly cools forming tube stock or a coating. This process is called a “cold process” (relative to the substrate material being coated) as the substrate temperature can be kept low during processing to avoid damage, metallurgical changes and distortion to the substrate material.
- the plasma gun described above comprises a copper anode and tungsten cathode, both of which are water cooled.
- Plasma gas argon, nitrogen, hydrogen, helium
- the plasma is initiated by a high voltage discharge which causes localized ionization and a conductive path for a DC arc to form between cathode and anode.
- the resistance heating from the arc causes the gas to reach extreme temperatures, dissociate and ionize to form a plasma.
- the plasma exits the anode nozzle as a free or neutral plasma flame (plasma which does not carry electric current).
- the electric arc extends down the nozzle, instead of shorting out to the nearest edge of the anode nozzle.
- This stretching of the arc is due to a thermal pinch effect.
- the plasma gun components must be constantly cooled with water to prevent the gun from melting down. Water is sent to the gun through the same lines as electrical power. Small temperature changes in the cooling water may affect the ability to produce high quality plasma coatings. Therefore, a water chiller can be used to help produce high quality tube stock and coatings. Cold gas around the surface of the water cooled anode nozzle being electrically non-conductive constricts the plasma arc, raising its temperature and velocity.
- Powder is fed into the plasma flame most commonly via an external powder port mounted near the anode nozzle exit.
- the powder is so rapidly heated and accelerated that spray distances can be in the order of 25 to 150 mm.
- plasma begins generation at 10,000° F.
- Most plasma guns run between 15,000° F. and 30,000° F. internally.
- the detonation gun shown in FIG. 14 basically consists of a long water cooled barrel with inlet valves for gases and powder. Oxygen and fuel (acetylene most common) are fed into the barrel along with a charge of powder. A spark from the spark plug is used to ignite the gas mixture and the resulting detonation heats and accelerates the powder to supersonic velocity down the barrel. A pulse of nitrogen is used to purge the barrel after each detonation. This process is repeated many times a second. The high kinetic energy of the hot powder particles on impact with the substrate result in a build up of a very dense and strong coating.
- Oxygen and fuel acetylene most common
- each of the above mentioned processes should incorporate either a moving thermal spray gun or a moving mandrel or substrate, or both, in order to uniformly disperse the material onto the mandrel to form tube stock or onto a stent to form a coating.
- This process is preferably accomplished through the use of a precision CNC machine.
- the mandrel can be formed of metal that shrinks in diameter when cooled, while at the same time heating the tube stock so that it expands radially outwardly. The mandrel can then be easily removed from the tube stock. Also, the mandrel and tube stock may both be heated and the difference in expansion rates causing separation between the two. The mandrel can also be removed from the tube stock by a process called cross-rolling.
- the tube stock, with the mandrel inside, is run through a series of crossed rollers that will flex the tube stock and impart a separation between the tube and the mandrel, which is then easily removed.
- the mandrel could be lubricated so as to provide a low friction surface from which to slide the off tube stock.
- one possibility for post processing includes mechanically processing or swaging the tube stock in order to develop desired mechanical properties for subsequent use as a stent.
- other post processing includes exerting high mechanical pressures onto the stent in order to develop the desired mechanical properties and tempering and hardening with a traveling ring furnace.
- the outer diameter and/or the inner diameter of the tube stock can be machined to size after being removed from the mandrel.
- the tube stock can also be reamed to size if desired.
- the tube stock can also be ground or drawn to final size.
- the invention also includes the process of coating a stent.
- the process includes thermally spray-forming material onto a stent pattern (see FIGS. 1-5 ) to form the coating where the type of thermal spray processing is selected from the group of cold spray, combustion, hvof, arc, and plasma.
- the material forming the coating is selected from the group of metals, metal alloys, polymers, ceramics, and cermets.
- other medical devices such as guide wires, lead tips, catheters, and markers also can be coated.
- One modification after the coating is applied can include varying the radial thickness oft he coating around the stent.
- the radial thickness can either be varied around the diameter or along the length of the stent.
- the materials used to coat the stent can be varied. In one instance metallic alloys can be sprayed onto the stent while in others ceramics, polymers and composites can be sprayed on as coatings.
- Additional post processing steps to reach the desired mechanical properties can include processing the stent in a traveling ring furnace where the material is melted and re-solidified as the ring travels down the length of the stent and processing the stent under high mechanical pressure in a vacuum to sinter grains of the stent together.
- the outer diameter of the stent can be post processed through centerless grinding or drawing to reduce the coating thickness.
- the inner diameter can be bored to improve both dimensions and surface roughness.
- FIG. 15 A machine-controlled laser cutting system is generally depicted as disclosed in U.S. Pat. No. 5,780,807, which is commonly owned and commonly assigned to Advanced Cardiovascular Systems, Inc., Santa Clara, Calif., and which is incorporated herein by reference.
- the tubing 21 is placed in a rotatable collet fixture 22 of a machine-controlled apparatus 23 for positioning the tubing relative to the laser 24 .
- the tubing is rotated and moved longitudinally relative to the laser, which is also machine-controlled.
- the laser selectively removes the material from the tubing by ablation and a pattern is cut into the tube.
- the tube is therefore cut into the discrete pattern of the finished stent.
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Inorganic Chemistry (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Mechanical Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Materials Engineering (AREA)
- Metallurgy (AREA)
- Organic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicinal Chemistry (AREA)
- Vascular Medicine (AREA)
- Surgery (AREA)
- Biomedical Technology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dermatology (AREA)
- Transplantation (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Ceramic Engineering (AREA)
- Physics & Mathematics (AREA)
- Plasma & Fusion (AREA)
- Materials For Medical Uses (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
The invention relates to devices for the treatment of heart disease and particularly to endo-arterial prostheses, which are commonly called stents. More particularly, the invention relates to methods of manufacturing and coating stents utilizing thermal spray processing (TSP). In one aspect the invention involves the use of TSP for the manufacture of fine grained tubing for subsequent use as a stent or other tubular or ring-based implant, or the manufacture of intermediate sized tubing that may then be drawn to final size tubing and for the coating of a stent. An average grain size of less than 64 microns is achieved by the invention resulting in a stent having an annular wall average thickness of about eight or more grains.
Description
- This invention relates to medical devices and more particularly, the invention relates to methods of manufacturing and coating medical devices utilizing thermal spray processing (TSP).
- Several interventional treatment modalities are presently used for heart disease, including balloon and laser angioplasty, atherectomy, and by-pass surgery. In typical coronary balloon angioplasty procedures, a guiding catheter having a distal tip is percutaneously introduced through the femoral artery into the cardiovascular system of a patient using a conventional Seldinger technique and advanced within the cardiovascular system until the distal tip of the guiding catheter is seated at the ostium of the coronary arteries. A guide wire is positioned within an inner lumen of a dilatation catheter and then both are advanced through the guiding catheter to the distal end thereof.
- The guide wire is first advanced out of the distal end of the guiding catheter into the patient's coronary vasculature until the distal end of the guide wire crosses a lesion to be dilated, then the dilatation catheter having an inflatable balloon on the distal portion thereof is advanced into the patient's coronary anatomy over the previously introduced guide wire until the balloon of the dilatation catheter is properly positioned across the lesion.
- Once in position across the lesion, the balloon is inflated to compress the plaque of the lesion against the inside of the artery wall and to otherwise expand the inner lumen of the artery. The balloon is then deflated so that blood flow can be resumed through the dilated artery and the dilatation catheter can be removed therefrom. Further details of dilatation catheters, guide wires, and devices associated therewith for angioplasty procedures can be found in U.S. Pat. No. 4,323,071 (Simpson-Robert); U.S. Pat. No. 4,439,185 (Lindquist); U.S. Pat. No. 4,516,972 (Samson); U.S. Pat. No. 4,538,622 (Samson, et al.); U.S. Pat. No. 4,554,929 (Samson, et al.); U.S. Pat. No. 4,616,652 (Simpson); U.S. Pat. No. 4,638,805 (Powell); U.S. Pat. No. 4,748,982 (Horzewski, et al.); U.S. Pat. No. 5,507,768 (Lau, et al.); U.S. Pat. No. 5,451,233 (Yock); and U.S. Pat. No. 5,458,651 (Klemm, et al.), which are hereby incorporated herein in their entirety by reference thereto.
- One problem that can occur during balloon angioplasty procedures is the formation of intimal flaps which can collapse and occlude the artery when the balloon is deflated at the end of the angioplasty procedure. Another problem characteristic of balloon angioplasty procedures is the large number of patients who are subject to restenosis in the treated artery. In the case of restenosis, the treated artery may again be subjected to balloon angioplasty or to other treatments such as by-pass surgery, if additional balloon angioplasty procedures are not warranted. However, in the event of a partial or total occlusion of a coronary artery by the collapse of a dissected arterial lining after the balloon is deflated, the patient may require immediate medical attention, particularly in the coronary arteries.
- A focus of recent development work in the treatment of heart disease has been directed to endoprosthetic devices referred to as stents. Stents are generally cylindrically shaped intravascular devices which are placed within an artery to hold it open. The device can be used to reduce the likelihood of restenosis and to maintain the patency of a blood vessel immediately after intravascular treatments. In some circumstances, they can also be used as the primary treatment device where they are expanded to dilate a stenosis and then left in place. Further details of stents can be found in U.S. Pat. No. 3,868,956 (Alfidi et al.); U.S. Pat. No. 4,512,338 (Balko et al.); U.S. Pat. No. 4,553,545 (Maass et al.); U.S. Pat. No. 4,733,665 (Palmaz); U.S. Pat. No. 4,762,128 (Rosenbluth); U.S. Pat. No. 4,800,882 (Gianturco); U.S. Pat. No. 4,856,516 (Hillstead); U.S. Pat. No. 4,886,062 (Wiktor); U.S. Pat. No. 5,421,955 (Lau); and U.S. Pat. No. 5,569,295 (Lam), which are hereby incorporated herein in their entirety by reference thereto.
- One method and system developed for delivering stents to desired locations within the patient's body lumen involves crimping a stent about an expandable member, such as a balloon on the distal end of a catheter, advancing the catheter through the patient's vascular system until the stent is in the desired location within a blood vessel, and then inflating the expandable member on the catheter to expand the stent within the blood vessel. The expandable member is then deflated and the catheter withdrawn, leaving the expanded stent within the blood vessel, holding open the passageway thereof.
- Commercially available 316L stainless steel tubing contains average grain sizes ranging from approximately 0.0025 inch (64 microns), ASTM grain size 5 to around 0.00088 inch (22 microns), ASTM grain size 8. These grain sizes result in anywhere from two to five grains across the tube thickness, and the stent subsequently manufactured from the tubing depending on the tube and stent strut thicknesses. Part of the limitation in achieving a finer grain size in this material arises from the number of draws and anneals the tubing must go through to achieve its final size. The potential for reducing the grain size exists by reducing the required number of heat-processing steps by reducing the starting size of the raw product that is then processed down into the tubing.
- Lowering the grain size and increasing the number of grains across the strut thickness of a stent allows the grains within the stent to act more as a continuum and less as a step function. The ideal result of processing the material to a smaller grain size would result in an average grain size of between approximately 1 and 10 microns, with a subsequent average number of grains across the strut thickness about eight or greater. Likewise, other medical devices will benefit from a reduction in grain size such as guide wires, ring markers, defibrillator lead tips, delivery system devices such as catheters, and the like.
- The present invention relates to methods of manufacturing and coating medical devices utilizing thermal spray processing (TSP). The process includes producing a coating having an average grain size of between 1 and 64 microns and providing a thin walled structure having a wall thickness of about eight or more grains. While the grain size for thin walled structures (such as stents) has been referred to herein as about eight or more grains, the number of grains does vary depending on wall thickness. Thus, for very thin walled structures the wall thickness may be between four and eight grains, but for most (but not all) stent applications it is desirable to have at least eight or more grains comprising the wall thickness.
- The invention involves the use of TSP for the manufacture of fine grained tubing for subsequent use as a medical device such as a stent or other tubular or ring-based implant, the manufacture of intermediate size tube that may then be drawn into final size tubing, and for the coating of a stent or other medical device. Medical devices which will benefit from the present invention include stents, guide wires, ring markers, tubular or wire based implants, defibrillator lead tips, and catheters and other delivery system devices. While the present invention TSP is utilized for the medical devices described herein, stents will be used as an example of the inventive manufacturing process and coating process disclosed and claimed herein.
- Thermal spray is a generic term for a broad class of related processes in which molten droplets of metals, ceramics, glasses, and/or polymers are sprayed onto a surface to produce a coating, to form a free-standing near-net-shape, or to create an engineered material with unique properties (e.g., strain-tolerant ceramics, metallic glasses, cermets, or metal/polymer composites).
- In principle, any material with a stable molten phase can be thermally sprayed, and a wide range of pure and composite materials are routinely sprayed for both research and industrial applications. Deposition rates are very high in comparison to alternative coating technologies. Deposit thicknesses of 0.1 to 1 mm are common, and thicknesses greater than 1 cm can be achieved with some materials.
- With regard to manufacturing, the invention relates to the overall manufacturing of tube stock and coatings, creating layered material and other materials through powder consolidation during spraying, with the additional potential of creating composite materials.
- As mentioned above, commercially available 316L stainless steel tubing contains average grain sizes ranging from approximately 0.0025 inch (64 microns), ASTM grain size 5 to around 0.00088 inch (22 microns), ASTM grain size 8. These grain sizes result in anywhere from two to five grains across the tube thickness, and the stent subsequently manufactured from this tubing depending on the tube and stent strut thicknesses. Part of the limitation in achieving a finer grain size in this material arises from the number of draws and anneals the tubing must go through to achieve its final size. The potential for reducing the grain size exists by reducing the required number of heat-processing steps by reducing the starting size of the raw product that is then processed down into the tubing.
- Lowering the grain size and increasing the number of grains across the strut thickness allows the grains within the stent to act more as a continuum and less as a step function. For example, the result of processing the material to a smaller grain size in a stent would result in an average grain size of between approximately 1 and 64 microns, with a subsequent average number of grains across the strut thickness about eight or greater. The average number of grains in a cross-section of a medical device depends upon the size of the device and the diameter of the grains.
- In one embodiment, the manufacturing process includes thermal spray processing. Thermal spray processing can be generally defined as a group of processes in which finely divided metallic or nonmetallic surfacing materials are deposited in a molten or semi-molten condition on a substrate to form a spray deposit. Cold spray thermal processing, to be discussed herein, is considered a thermal spray process although the materials projected onto a surface are not necessarily molten or semi-molten. TSP includes several variants such as cold spraying, combustion spraying, arc spraying, high velocity oxy-fuel spraying, and plasma spraying. Currently sprayed materials include elements, metallic alloys, ceramics, composites and polymers. TSP can be considered to be a net or near net shaped process. This means that the product that comes out of the thermal spray process is close to or at the desired size and shape of the final product. This process can be used not only to coat a stent but also to manufacture tube stock that is used in place of gun drilled or extruded rod or subsequent tube manufacturing. Some factors to consider when spray forming include the grain size, porosity, and dimensional tolerances of the sprayed part. Post-processing can assist when one or more of these factors is not as desired for the final product. Thus TSP processing is presented here both with and without post-processing of the material.
- Some advantages of thermal processing include the versatility with respect to feed materials (metals, ceramics, and polymers in the form of wires, rods, or powders); the capacity to form barrier and functional coatings on a wide range of substrates; the ability to create freestanding structures for net-shape manufacturing of high-performance ceramics, composites, and functionally graded materials; and the rapid-solidification synthesis of specialized materials.
- TSP may be used to spray-form tube stock on top of a removable mandrel. The thickness of the tube may be varied by spraying more or less material, and the inner diameter dimensions may be varied by changing the size of the mandrel. The inner mandrel may be made of a substance that melts out or that is coated with a substance that allows easy removal of the finished sprayed tube. If the grain size, porosity, and dimensional tolerances (including wall runout, wall thickness, concentricity and surface roughness) are as desired, the mandrel may be removed and the sprayed tube is ready for further processing into a stent or other tubular or ring-shaped product. To create a ring-shaped product from a tube product, the tube is sprayed to the desired dimensions and then sliced in the transverse direction to result in rings of the desired size.
- There are several potential post-processing operations that may take place on a sprayed tube. Grain size, porosity, and final dimensions are a few of the incentives for performing post processing.
- Grain size of the finished tube depends on numerous factors, including the size of the particles being sprayed, the formation, impact and rate of solidification of the sprayed material, and the length of time the material is heated above a temperature that allows significant grain growth. For a metallic tube, if the grain size is larger than desired, the tube may be swaged to introduce heavy dislocation densities, then heat treated to recrystallize the material into finer grains. Alternatively, different material forms may be taken through a drawing or other working and heat treat processes to recrystallize the tubing. The type and amount of working allowed depends on the material, e.g., ceramics may require a high temperature working step while metals and composites may be workable at room temperature. Grain-size strengthening is where there is an increase in strength of a material due to a decrease in the grain size. The larger grain-boundary area more effectively blocks dislocation movement. The outer diameter of the tube usually requires a machining step of some sort to smooth the surface after the swaging process, and the same may be true before the tubing can be properly drawn.
- By the very nature of the spray processing itself, the sprayed material may contain porosity, or small voids. These may be minimized or eliminated through control of the TSP parameters. The potential exists that the tube may need to be post-processed to eliminate this feature. One potential method of post processing involves a traveling ring furnace, where the material is melted and re-solidified as the ring travels down the length of the tube. This method requires close control to prevent preferential segregation of elements along with the melt pool. Another method is to process the material under high mechanical pressure to sinter the grains together; this method is generally used for powder processing. As porosity is difficult to remove from a material, however, the best form of elimination is to ensure that the TSP parameters are such that the porosity is not present in the first place.
- While TSP is a near-net shape process, variability in the process itself may require post-processing so that the product achieves the required dimensional tolerances. Such processing may include machining of some form or centerless grinding the outer diameter oft he sprayed tube to reduce wall thickness variability and to improve the surface finish. The inner diameter dimensions and surface finish should be dependant on the mandrel that it is sprayed on. If the starting size of the sprayed tube is large enough, it may be desirous to bore and ream or just ream the inner diameter for both dimension and surface roughness improvement. An alternate method is to perform a drawing operation on the TSP tube to draw the tube to the desired final size. In this case, if the outer diameter is too rough, the tube will need to be machined or ground prior to the drawing operation.
- With regard to coatings, TSP may be used to coat an object with a desired material. The thickness of the coating may be varied by spraying more or less material, and this thickness may be varied along the length and around the diameter of the product. The advantage of using TSP as a coating process is the wide variety of materials that may be sprayed, including metallic elements, known and novel metallic alloys, ceramics, composites and polymers. The potential exists to spray stents, guide wires, and other products that require a coating. If the grain or node size, material density or porosity, and dimensional tolerances are as desired, the part should be ready for any post-passivation or other desired steps if the coating is considered to be an intermediate step in finishing the part.
- Several potential post-processing operations may be used on a coated part. Grain or node size, material density or porosity, and final dimensions will be considered here as the parameters for performing post-processing.
- Grain size or node size of the finished coating will depend on numerous factors, including the size oft he particles being sprayed, the formation, impact and rate of solidification of the sprayed material, and the length of time the material is heated above a temperature that allows significant grain growth.
- For a metallic coating, one modification to grain size that may be made is to heat treat the coating and grow the grains. It is generally difficult to work the stent and coating material in a way that introduces a high dislocation density that may then be used to recrystallize the material. For a metallic wire coating, the wire may be swaged or drawn to produce a higher dislocation density, then annealed to recrystallize to a smaller grain size; the same may be true of a tube that is coated. For a ceramic coating, heating may be a post-processing step, while for a polymeric coating, further cross-linking may be necessary.
- As mentioned above the sprayed material may contain porosity, or small voids. These may be minimized or eliminated through control of the TSP parameters. The potential exists that the part may need to be post-processed to eliminate this feature. One potential method of post processing a metallic, ceramic or composite coating involves a traveling ring furnace where the material is melted and re-solidified as the ring travels down the length of the part. This method requires close control to prevent preferential segregation of elements along with the melt pool as well as to prevent unwanted migration of the coating into the underlying material. Another method would be to process the material under high mechanical pressure in a vacuum to sinter the grains together. This method is generally used for powder processing. As porosity is difficult to remove from a material if “no porosity” is a coating requirement, the best form of elimination would be to ensure that the TSP parameters are such that the porosity is not present in the first place.
- While TSP is a near-net shape process, variability in the process itself may require post-processing to finalize the coating to required dimensional tolerances. Mechanical post-processing of a stent would be difficult because of the diminutive nature of the stent. Post-processing of a wire or tubular product is less difficult. For the latter products, outer diameter processing may include machining, e.g., centerless grinding, or drawing to reduce coating thickness variability and to improve the surface finish. If a part is sprayed on the inner diameter, it may be desirous to machine out the inner diameter by, for example, boring and/or reaming, for both dimension and surface roughness improvement.
- As mentioned above, thermal spray processing (TSP) includes several variants such as cold spraying, combustion spraying, arc spraying, high velocity oxy-fuel spraying, and plasma spraying. The following is a brief summary of the basic components and functioning of one type of each of the above mentioned thermal spray processes of the invention.
- In cold spray thermal processing, generally powder particles are introduced into a high pressure gas where both the gas and particles enter a supersonic jet. The jet stream is directed against a mandrel in order to coat the mandrel with particles and form either tube stock or a coating. The cold spray process involves minimal heat input to the feedstock powder or the substrate thus making it possible to deposit thermally sensitive as well as conventional materials. The process generally produces high density, low residual stress deposits with low oxide contents.
- The combustion wire thermal spray process is basically the spraying of molten metal onto a surface to provide tube stock or a coating. Material in wire form is melted in a flame (oxy-acetylene flame is the most common) and atomized using compressed air to form a fine spray. When the spray contacts the prepared surface of a substrate material, the fine molten droplets rapidly solidify forming tube stock or a coating. This process carried out correctly is called a “cold process” (relative to the substrate material being coated) as the substrate temperature can be kept low during processing thereby avoiding damage, metallurgical changes and distortion to the substrate material.
- The combustion powder thermal spray process is also basically the spraying of molten material onto a surface to provide tube stock or a coating. Here though, material in powder form is melted in a flame (oxy-acetylene or hydrogen is the most common) to form a fine spray. When the spray contacts the prepared surface of a substrate material, the fine molten droplets rapidly solidify forming tube stock or a coating. This process carried out correctly is called a “cold process” (relative to the substrate material being coated) as the substrate temperature can be kept low during processing thus avoiding damage, metallurgical changes and distortion to the substrate material.
- In combustion wire spray processing, a wide range of material may be easily processed into powder form, giving a large choice of materials to use in making tube stock and/or coating devices. The process is limited only by materials with higher melting temperatures than the flame can provide or if the material decomposes on heating. In both, benefits include low capital investment, simplicity of operation, and high deposit efficiency.
- In the arc spray process a pair of electrically conductive wires are melted by means of an electric arc. The molten material is atomized by compressed air and propelled towards the substrate surface. The impacting molten particles on the substrate rapidly solidify to form tube stock or a coating. This process carried out correctly is called a “cold process” (relative to the substrate material being coated) as the substrate temperature can be kept low during processing avoiding damage, metallurgical changes and distortion to the substrate material. Benefits of arc spray substrates and coatings includes high bond strength and density, low internal stresses, high thickness capability, and high quality microstructures.
- The hvof (high velocity oxygen fuel) thermal spray process is similar to the combustion powder spray process except that hvof has been developed to produce extremely high spray velocity. Several hvof guns use different methods to achieve high velocity spraying. One method is basically a high pressure water cooled combustion chamber and long nozzle. Fuel (kerosene, acetylene, propylene and hydrogen) and oxygen are fed into the chamber, combustion produces a hot high pressure flame which is forced down a nozzle increasing its velocity. Powder may be fed axially into the combustion chamber under high pressure or fed through the side of laval type nozzle where the pressure is lower. Another method uses a simpler system of a high pressure combustion nozzle and air cap. Fuel gas (propane, propylene or hydrogen) and oxygen are supplied at high pressure, combustion occurs outside the nozzle but within an air cap supplied with compressed air. The compressed air pinches and accelerates the flame and acts as a coolant for the gun. Powder is fed at high pressure axially from the center of the nozzle. Benefits include high particle velocity, low particle temperatures, and time at temperature during the spraying process, which reduces oxidation and degradation of constituents.
- The plasma spray process is basically the spraying of molten or heat softened material onto a surface to provide tube stock or a coating. Material in the form of powder is injected into a very high temperature plasma flame, where it is rapidly heated and accelerated to a high velocity. The hot material impacts on the substrate surface and rapidly cools forming tube stock or a coating. This process carried out correctly is called a “cold process” (relative to the substrate material being coated) as the substrate temperature can be kept low during processing thus avoiding damage, metallurgical changes and distortion to the substrate material.
- The plasma gun comprises a copper anode and tungsten cathode, both of which are water cooled. Plasma gas (argon, nitrogen, hydrogen, helium) flows around the cathode and through the anode which is shaped as a constricting nozzle. The plasma is initiated by a high voltage discharge which causes localized ionization and a conductive path for a DC arc to form between cathode and anode. The resistance heating from the arc causes the gas to reach extreme temperatures, dissociate and ionize to form a plasma. The plasma exits the anode nozzle as a free or neutral plasma flame (plasma which does not carry electric current). When the plasma is stabilized and ready for spraying, the electric arc extends down the nozzle, instead of shorting out to the nearest edge of the anode nozzle. This stretching of the arc is due to a thermal pinch effect. Cold gas around the surface of the water cooled anode nozzle, being electrically non-conductive, constricts the plasma arc, raising its temperature and velocity. Powder is fed into the plasma flame most commonly via an external powder port mounted near the anode nozzle exit. The powder is so rapidly heated and accelerated that spray distances can be on the order of 25 to 150 mm. Benefits associated with plasma spray include a high degree of flexibility, the largest choice of substrate and coating materials, and high production spray rates in which the process can be highly automated.
- The detonation gun basically consists of a long water cooled barrel with inlet valves for gases and powder. Oxygen and fuel (acetylene is the most common) is fed into the barrel along with a charge of powder. A spark is used to ignite the gas mixture and the resulting detonation heats and accelerates the powder to supersonic velocity down the barrel. A pulse of nitrogen is used to purge the barrel after each detonation. This process is repeated many times a second. The high kinetic energy of the hot powder particles on impact with the substrate result in a build up of a very dense and strong tube stock or coating.
- The foregoing TSP processes provide a tubing product that can be formed into a stent that has strut cross-sections having an average grain size of less than or equal to 10 microns or an average thickness of about eight or more grains depending on the strut thickness. As stated, the disclosed processes also are applicable to the medical devices described herein.
- Other features and advantages of the invention will become apparent from the following detailed description, taken in conjunction with the accompanying drawings, which illustrate, by way of example, the features of the invention.
-
FIG. 1 is an elevational view, partially in section, of a stent embodying features of the invention which is mounted on a delivery catheter and disposed within a damaged artery. -
FIG. 2 is an elevational view, partially in section, similar to that shown inFIG. 1 wherein the stent is expanded within an artery. -
FIG. 3 is an elevational view, partially in section showing the expanded stent within the artery after withdrawal of the delivery catheter. -
FIG. 4 is a perspective view of a stent embodying in an unexpanded state, with one end of the stent being shown in an exploded view to illustrate the details thereof. -
FIG. 5 is a plan view of a flattened section of a stent of the invention which illustrates the undulating pattern of the stent shown inFIG. 4 . -
FIG. 5A is a cross-sectional view taken along the line 5A-5A inFIG. 5 . -
FIG. 6 is a schematic diagram of a spherical particle impinged onto a flat substrate (splat). -
FIG. 7 is a schematic diagram of a thermal spray coating. -
FIG. 8 is a schematic diagram of a cold spray thermal spray processing apparatus. -
FIG. 9 is a schematic diagram of a combustion wire thermal spray processing apparatus. -
FIG. 10 is a schematic diagram of a combustion powder thermal spray processing apparatus. -
FIG. 11 is a schematic diagram of an arc wire thermal spray processing apparatus. -
FIG. 12 is a schematic diagram of an hvof thermal spray processing apparatus. -
FIG. 13 is a schematic diagram of a plasma thermal spray processing apparatus. -
FIG. 14 is a schematic diagram of a detonation thermal spray processing apparatus. -
FIG. 15 is a schematic representation of equipment for selectively cutting the tubing in the manufacture of stents, in accordance with the present invention. - The present invention relates to manufacturing processes for forming a medical device such as tube stock or piece of tubing, a wire, or to provide a coating on a tube for subsequent use as an intravascular stent, a guide wire, a ring marker, defibrillator lead tips, catheters and delivery systems. While virtually any medical device that is implanted or used in the body will benefit from the present invention, the invention as applied to stents is described herein as only an example and is not meant to be limiting. Thus, tube stock or wires made or coated by the process of the present invention might be used for stents, guide wires, catheters, markers, lead tips, and the like.
- Stents are well known in the art and can have many different types of patterns and configurations. The following description of an intravascular stent as shown in
FIGS. 1-5A , is a typical stent pattern made from stainless steel tubing. Other patterns are well known in the art and the foregoing description of a stent and delivery system is by way of example, and is not meant to be limiting. - Referring now to the drawings, and particularly
FIG. 1 thereof, there is shown astent 10 mounted onto adelivery catheter 11. The stent is a high precision patterned tubular device that typically includes a number of radially expandable cylindrical elements or rings 12 disposed generally coaxially and interconnected bylinks 13 disposed between adjacent rings. The delivery catheter has an expandable portion orballoon 14 for expanding the stent within anartery 15. - The
typical delivery catheter 11 onto which thestent 10 is mounted is similar in operation to a conventional balloon dilatation catheter for angioplasty procedures. Portions oft he proximal end of such catheters can be made of metal tubing or metal wire. Theballoon 14 may be formed of suitable materials such as polyethylene, polyethylene terephthalate, polyvinyl chloride, nylon and ionomers such as Surlyn® of the manufactured by the Polymer Products Division oft he Du Pont Company. Other polymers may also be used. In order for the stent to remain in place on the balloon during delivery to the site of the damage within theartery 15, the stent is compressed onto the balloon. - The delivery of the
stent 10 is accomplished in the following manner. The stent is first mounted onto theinflatable balloon 14 on the distal extremity of thedelivery catheter 11. The catheter-stent assembly is introduced within the patient's vasculature in a conventional Seldinger technique through a guiding catheter (not shown). Aguide wire 18 is disposed across the damaged arterial section and then the catheter/stent assembly is advanced over the guide wire within the artery until the stent is directly within the target site. As stated, guide wires also will benefit from the processes oft he present invention. The balloon of the catheter is expanded, expanding the stent against the artery, which is illustrated inFIG. 2 . While not shown in the drawing, the artery is preferably expanded slightly by the expansion of the stent to seat or otherwise fix the stent to prevent movement. In some circumstances, during the treatment of stenotic portions of an artery, the artery may have to be expanded considerably in order to facilitate passage of blood or other fluid therethrough. - The
stent 10 serves to hold open theartery 15 after theballoon 14 is deflated and thecatheter 11 is withdrawn, as illustrated byFIG. 3 . Due to the formation of the stent from an elongated tubular member, the undulating component of therings 12 of the stent is relatively flat in transverse cross-section, so that when the stent is expanded, the rings are pressed into the wall of the artery and, as a result, do not interfere with the blood flow through the artery. Furthermore, the closely spaced rings at regular intervals provide uniform support for the wall of the artery and, consequently, are well adapted to hold open the artery, as illustrated inFIGS. 2 and 3 . -
FIG. 4 is an enlarged perspective view of thestent 10 shown inFIG. 1 with one end of the stent shown in an exploded view to illustrate in greater detail the placement oflinks 13 between adjacent radially expandable rings. In the embodiment shown inFIG. 4 , the stent has three links between adjacent radially expandable rings that are approximately 120° apart. Each pair of links on one side of a ring are circumferentially offset 60° from the pair on the other side of the ring. The alternation oft he links results in a stent which is longitudinally flexible in essentially all directions. - As best observed in
FIGS. 4 and 5 , therings 12 are in the form of aserpentine pattern 30. As previously mentioned, each ring is connected bylinks 13. The serpentine pattern is made up of a plurality ofU-shaped members 31, W-shapedmembers 32, and Y-shapedmembers 33, each having a different radius so that expansion forces are more evenly distributed over the various members. Other stent patterns can be formed by utilizing the processes of the present invention and the embodiment illustrated inFIGS. 1-5 are by way of example and are not intended to be limiting. - The afore described
illustrative stent 10 and similar stent structures can be made in many ways. The preferred method of making the disclosed stent in this invention is through a process utilizing thermal spray processing. - For use in coronary arteries, the stent diameter is very small, so the tubing from which it is made must necessarily also have a small diameter. Typically, the stent has an outer diameter on the order of about 0.030 to 0.060 inch in the unexpanded condition, equivalent to the tubing from which the stent is made, and can be expanded to an outer diameter of 0.10 inch or more. The wall thickness of the tubing is about 0.0020 to 0.010 inch. As with the foregoing stent dimensions, all of the medical devices that can be formed utilizing the present invention can vary substantially in size and shape so that the disclosed dimensions and shapes are representative examples only and are not meant to be limiting.
- In its most basic form, the process of manufacturing tube stock or a coating in this invention consists of first selecting a thermal spray processing apparatus from the group consisting cold spray, combustion, hvof, arc, and plasma. Material selected from the group consisting of metals, alloys, polymers, ceramics, and cermets is then thermally spray formed onto either a mandrel to form tube stock or a stent to form a coating. Finally, the tube stock or coated stent is removed for further processing.
- Thermal spray deposits are generally composed of cohesively bonded splats as shown in
FIGS. 6 and 7 resulting from the impact, spreading, and rapid solidification of a high flux of particles with deformed shapes. The physical properties and behavior of the deposit depend on many factors including the cohesive strength among the splats, the size and morphology oft he porosity, and the occurrence of cracks and defects and on the ultrafine-grained microstructure within the splats themselves. - The cold spray method offers a means for expanding the operational window for coating and forming stents to permit a variety of materials to be deposited with much lower thermal exposure than encountered in the traditional processes. The method exploits properties of gas dynamics which permit supersonic gas streams and attendant particle velocities to be obtained. The method additionally permits a high degree of spatial control by virtue of the gas nozzle characteristics and generally short standoff distances which can be employed. This results in a uniform structure of the coating or tube stock with the substantially preserved formation of the powder material without phase transformations and hardening, i.e., the coatings applied do not crack, their corrosion resistance, microhardness, and cohesion and adhesion strength are enhanced. The process includes producing a coating having an average grain size of between 1 and 64 microns and providing a thin walled structure having a wall thickness of about eight or more grains. While the grain size for thin walled structures (such as stents) has been referred to herein as about eight or more grains, the number of grains does vary depending on wall thickness. Thus, for very thin walled structures the wall thickness may be between four and eight grains, but for most (but not all) stent applications it is desirable to have at least eight or more grains comprising the wall thickness.
- Typical values for tensile adhesion of the cold spray coatings are in the range of 30-801 MPa (4.4-11.6 ksi), with porosities in the range of 1-10 volume percent, deposit thicknesses ranging from 10 microns to 10 millimeters, deposition rates in the range of 0.010 to about 0.080 m3 per hour, and deposition efficiencies in the range of 50-80%. Several considerations are the dependency of porosity on the ambient spray environment, powder characteristics (i.e., particle size and size distribution), and thermal-spray parameters (e.g., powder level, gas-flow features, and spray distance). The spray environment will have a significant influence on, for example, oxidation of metals, leading to greater porosity.
- One embodiment utilizes cold spray thermal processing to manufacture the tube stock and apply coatings as shown in
FIG. 8 . In this process, particles of a powder of at least one first material are selected from the group including metals, metal alloys, or polymers and mechanical mixture of a metal and an alloy. The preferred particle size ranges from about 1 to 64 microns. The powder is fed through the powder feeder and then introduced into a gas selected from the group of Nitrogen (N2), Oxygen (O2), Air, Helium (He), Argon (Ar), Xenon (Xe), or Carbon Dioxide (CO2). The gas also passes through the heater. Both the gas and particles are then fed into the supersonic nozzle with an inlet temperature between about 380 to 420° Celsius. The corresponding inlet velocity ranges from about 300 to about 1,200 m/sec and the inlet pressure is preferred to be between 1.5 to 2.5 Mpa. The nozzle is then directed against a mandrel which is placed 8 to 10 mm away. The mandrel is thereafter coated with the particles to form the tube stock or coating desired. Finally, the tube stock or coated stent is removed from the mandrel after it is formed. - The combustion wire thermal spray process shown in
FIG. 9 is basically the spraying of molten particles onto a mandrel to produce tube stock or a coating. The wire is propelled and melted into the flame (oxy-acetylene flame most common) and atomized by the compressed air to form a fine spray. When the spray contacts the prepared surface, the fine molten droplets rapidly solidify forming tube stock or a coating. This process, carried out correctly, is called a “cold process” (relative to the substrate material being coated) as the substrate temperature can be kept low during processing thus avoiding damage, metallurgical changes and distortion to the substrate material. - The combustion powder thermal spray process shown in
FIG. 10 is also basically the spraying of molten material onto a surface to provide tube stock or a coating. Here though, powder is propelled and melted into the flame (oxy-acetylene or hydrogen most common) to form a fine spray. When the spray contacts the prepared surface, the fine molten droplets rapidly solidify forming tube stock or a coating. This process, carried out correctly, is also called a “cold process” (relative to the substrate material being coated) as the substrate temperature can be kept low during processing thus avoiding damage, metallurgical changes and distortion to the substrate material. - In combustion wire spray processing there is a wide range of materials that can be easily processed into powder form giving a larger choice of coatings. The process is only limited by materials with higher melting temperatures than the flame can provide or if the material decomposes on heating.
- In the arc spray process shown in
FIG. 11 , a pair of electrically conductive wires are melted by means of an electric arc created between the two. The molten material is atomized by the compressed air and propelled towards the substrate surface. The impacting molten particles on the substrate rapidly solidify to form tube stock or a coating. This process, carried out correctly, is called a “cold process” (relative to the substrate material being coated) as the substrate temperature can be kept low during processing thus avoiding damage, metallurgical changes and distortion to the substrate material. - The hvof (high velocity oxygen fuel) thermal spray process shown in
FIG. 12 is similar to the combustion powder spray process except that hvof has been developed to produce extremely high spray velocities. There are a number of hvof guns which use different methods to achieve high velocity spraying. The method shown is basically a high pressure water cooled combustion chamber and long nozzle. Fuel (kerosene, acetylene, propylene and hydrogen) and oxygen are fed into the chamber where combustion produces a hot high pressure flame which is forced down a nozzle thereby increasing its velocity. The powder may be fed axially into the combustion chamber under high pressure or fed through the side of laval type nozzle where the pressure is lower. Another method (not shown here) uses a simpler system of a high pressure combustion nozzle and air cap. Fuel gas (propane, propylene or hydrogen) and oxygen are supplied at high pressure, combustion occurs outside the nozzle but within an air cap supplied with compressed air. The compressed air pinches and accelerates the flame and acts as a coolant for the gun. Powder is fed at high pressure axially from the center of the nozzle. The gas and particle velocity exiting an hvof gun can be in excess of 2500 feet per second. The velocity of the metallic particles causes friction through kinetic energy when the particles make contact with a substrate. This high energy can aid in the melting and adhesion of the particles to the substrate. Further, the gas temperature is usually very high, ranging from 2500° to 4500° F. - The plasma spray process shown in
FIG. 13 is basically the spraying of molten or heat softened material onto a surface to provide tube stock or a coating. Powdered material is directed through the powder injection and into the high temperature plasma flame, where it is rapidly heated and accelerated to a high velocity. The hot material impacts on the substrate surface and rapidly cools forming tube stock or a coating. This process is called a “cold process” (relative to the substrate material being coated) as the substrate temperature can be kept low during processing to avoid damage, metallurgical changes and distortion to the substrate material. - The plasma gun described above comprises a copper anode and tungsten cathode, both of which are water cooled. Plasma gas (argon, nitrogen, hydrogen, helium) flows around the cathode and through the anode which is shaped as a constricting nozzle. The plasma is initiated by a high voltage discharge which causes localized ionization and a conductive path for a DC arc to form between cathode and anode. The resistance heating from the arc causes the gas to reach extreme temperatures, dissociate and ionize to form a plasma. The plasma exits the anode nozzle as a free or neutral plasma flame (plasma which does not carry electric current). When the plasma is stabilized and ready for spraying, the electric arc extends down the nozzle, instead of shorting out to the nearest edge of the anode nozzle. This stretching of the arc is due to a thermal pinch effect. Due to the tremendous heat, the plasma gun components must be constantly cooled with water to prevent the gun from melting down. Water is sent to the gun through the same lines as electrical power. Small temperature changes in the cooling water may affect the ability to produce high quality plasma coatings. Therefore, a water chiller can be used to help produce high quality tube stock and coatings. Cold gas around the surface of the water cooled anode nozzle being electrically non-conductive constricts the plasma arc, raising its temperature and velocity. Powder is fed into the plasma flame most commonly via an external powder port mounted near the anode nozzle exit. The powder is so rapidly heated and accelerated that spray distances can be in the order of 25 to 150 mm. Typically, plasma begins generation at 10,000° F. Most plasma guns run between 15,000° F. and 30,000° F. internally.
- The detonation gun shown in
FIG. 14 basically consists of a long water cooled barrel with inlet valves for gases and powder. Oxygen and fuel (acetylene most common) are fed into the barrel along with a charge of powder. A spark from the spark plug is used to ignite the gas mixture and the resulting detonation heats and accelerates the powder to supersonic velocity down the barrel. A pulse of nitrogen is used to purge the barrel after each detonation. This process is repeated many times a second. The high kinetic energy of the hot powder particles on impact with the substrate result in a build up of a very dense and strong coating. - There are many possible variations on the above mentioned processes for forming tube stock or coating. Because the tube stock and coatings sought to be manufactured here are cylindrical, each of the above mentioned processes should incorporate either a moving thermal spray gun or a moving mandrel or substrate, or both, in order to uniformly disperse the material onto the mandrel to form tube stock or onto a stent to form a coating. This process is preferably accomplished through the use of a precision CNC machine.
- For removal of the tube stock after it is formed, it may be beneficial to either melt or shrink the mandrel's diameter to ease removal of the tube stock. For example, the mandrel can be formed of metal that shrinks in diameter when cooled, while at the same time heating the tube stock so that it expands radially outwardly. The mandrel can then be easily removed from the tube stock. Also, the mandrel and tube stock may both be heated and the difference in expansion rates causing separation between the two. The mandrel can also be removed from the tube stock by a process called cross-rolling. The tube stock, with the mandrel inside, is run through a series of crossed rollers that will flex the tube stock and impart a separation between the tube and the mandrel, which is then easily removed. Alternatively, the mandrel could be lubricated so as to provide a low friction surface from which to slide the off tube stock.
- Before the tube stock is removed from the mandrel one possibility for post processing, includes mechanically processing or swaging the tube stock in order to develop desired mechanical properties for subsequent use as a stent. After the tube stock is removed from the mandrel other post processing includes exerting high mechanical pressures onto the stent in order to develop the desired mechanical properties and tempering and hardening with a traveling ring furnace.
- For correct sizing, the outer diameter and/or the inner diameter of the tube stock can be machined to size after being removed from the mandrel. The tube stock can also be reamed to size if desired. The tube stock can also be ground or drawn to final size.
- As mentioned above, the invention also includes the process of coating a stent. The process includes thermally spray-forming material onto a stent pattern (see
FIGS. 1-5 ) to form the coating where the type of thermal spray processing is selected from the group of cold spray, combustion, hvof, arc, and plasma. The material forming the coating is selected from the group of metals, metal alloys, polymers, ceramics, and cermets. As should be clear, other medical devices such as guide wires, lead tips, catheters, and markers also can be coated. - One modification after the coating is applied can include varying the radial thickness oft he coating around the stent. In this process, the radial thickness can either be varied around the diameter or along the length of the stent. Further, the materials used to coat the stent can be varied. In one instance metallic alloys can be sprayed onto the stent while in others ceramics, polymers and composites can be sprayed on as coatings.
- In one embodiment it may be desirable to spray a metallic coating onto the stent, heat the coating, and grow the grains after the coating is applied to the stent. In all instances, it may be possible to mechanically process or swage, anneal, heat treat, or cross link process the stent with the coating thereon in order to develop desired mechanical properties.
- Additional post processing steps to reach the desired mechanical properties can include processing the stent in a traveling ring furnace where the material is melted and re-solidified as the ring travels down the length of the stent and processing the stent under high mechanical pressure in a vacuum to sinter grains of the stent together. To finish the coated stent to desired dimensions, the outer diameter of the stent can be post processed through centerless grinding or drawing to reduce the coating thickness. The inner diameter can be bored to improve both dimensions and surface roughness.
- After thermal spray processing, it may be preferred to cut the tubing in the desired pattern by means of a machine-controlled laser as illustrated schematically in
FIG. 15 . A machine-controlled laser cutting system is generally depicted as disclosed in U.S. Pat. No. 5,780,807, which is commonly owned and commonly assigned to Advanced Cardiovascular Systems, Inc., Santa Clara, Calif., and which is incorporated herein by reference. Thetubing 21 is placed in arotatable collet fixture 22 of a machine-controlledapparatus 23 for positioning the tubing relative to thelaser 24. According to machine-encoded instructions, the tubing is rotated and moved longitudinally relative to the laser, which is also machine-controlled. The laser selectively removes the material from the tubing by ablation and a pattern is cut into the tube. The tube is therefore cut into the discrete pattern of the finished stent. - While several particular forms of the invention have been illustrated and described, it will also be apparent that various modifications can be made without departing from the scope of the invention.
Claims (4)
1. A wire, comprising:
an elongated wire formed of grains and having a diameter of at least nine grains where the average diameter of the grains is less than 64 microns.
2. The wire of claim 1 , wherein the wire is processed to form a medical device taken from the group of devices including stents, guide wires, catheters, markers, and lead tips.
3. A medical device processed from an elongated wire formed of grains and having a diameter of at least nine grains where the average diameter of the grains is less than 64 microns.
4. The wire of claim 3 , wherein the medical device is selected from the group of devices consisting of stents, guide wires, catheters, markers, and lead tips.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/724,766 US20070166496A1 (en) | 2001-06-12 | 2007-03-16 | Method and apparatus for thermal spray processing of medical devices |
US11/784,267 US20070184228A1 (en) | 2001-06-12 | 2007-04-05 | Method and apparatus for thermal spray processing of medical devices |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/880,514 US7201940B1 (en) | 2001-06-12 | 2001-06-12 | Method and apparatus for thermal spray processing of medical devices |
US11/724,766 US20070166496A1 (en) | 2001-06-12 | 2007-03-16 | Method and apparatus for thermal spray processing of medical devices |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/880,514 Division US7201940B1 (en) | 2001-06-12 | 2001-06-12 | Method and apparatus for thermal spray processing of medical devices |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/784,267 Division US20070184228A1 (en) | 2001-06-12 | 2007-04-05 | Method and apparatus for thermal spray processing of medical devices |
Publications (1)
Publication Number | Publication Date |
---|---|
US20070166496A1 true US20070166496A1 (en) | 2007-07-19 |
Family
ID=37648741
Family Applications (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/880,514 Expired - Lifetime US7201940B1 (en) | 2001-06-12 | 2001-06-12 | Method and apparatus for thermal spray processing of medical devices |
US10/331,838 Expired - Fee Related US7163715B1 (en) | 2001-06-12 | 2002-12-30 | Spray processing of porous medical devices |
US11/582,703 Expired - Fee Related US7514122B2 (en) | 2001-06-12 | 2006-10-17 | Method and apparatus for spray processing of porous medical devices |
US11/724,766 Abandoned US20070166496A1 (en) | 2001-06-12 | 2007-03-16 | Method and apparatus for thermal spray processing of medical devices |
US11/784,267 Abandoned US20070184228A1 (en) | 2001-06-12 | 2007-04-05 | Method and apparatus for thermal spray processing of medical devices |
US12/406,866 Expired - Fee Related US7854958B2 (en) | 2001-06-12 | 2009-03-18 | Method and apparatus for spray processing of porous medical devices |
Family Applications Before (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/880,514 Expired - Lifetime US7201940B1 (en) | 2001-06-12 | 2001-06-12 | Method and apparatus for thermal spray processing of medical devices |
US10/331,838 Expired - Fee Related US7163715B1 (en) | 2001-06-12 | 2002-12-30 | Spray processing of porous medical devices |
US11/582,703 Expired - Fee Related US7514122B2 (en) | 2001-06-12 | 2006-10-17 | Method and apparatus for spray processing of porous medical devices |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/784,267 Abandoned US20070184228A1 (en) | 2001-06-12 | 2007-04-05 | Method and apparatus for thermal spray processing of medical devices |
US12/406,866 Expired - Fee Related US7854958B2 (en) | 2001-06-12 | 2009-03-18 | Method and apparatus for spray processing of porous medical devices |
Country Status (1)
Country | Link |
---|---|
US (6) | US7201940B1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080262600A1 (en) * | 1999-03-16 | 2008-10-23 | Jalisi Marc M | Multilayer stent |
US20090299463A1 (en) * | 2001-11-30 | 2009-12-03 | Advanced Cardiovascular Systems, Inc. | Modified Surface For An Implantable Device And A Method Of Producing The Same |
US8123799B1 (en) | 2001-11-30 | 2012-02-28 | Advanced Cardiovascular Systems, Inc. | Modified implantable device surface and a method of making the same |
US20140364960A1 (en) * | 2012-01-18 | 2014-12-11 | Meko Laserstrahl-Materialbearbeitungen E.K | Nickel-free iron alloy for stents |
Families Citing this family (205)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7959664B2 (en) | 1996-12-26 | 2011-06-14 | Medinol, Ltd. | Flat process of drug coating for stents |
US6951572B1 (en) * | 1997-02-20 | 2005-10-04 | Endologix, Inc. | Bifurcated vascular graft and method and apparatus for deploying same |
US7713297B2 (en) * | 1998-04-11 | 2010-05-11 | Boston Scientific Scimed, Inc. | Drug-releasing stent with ceramic-containing layer |
US6261316B1 (en) | 1999-03-11 | 2001-07-17 | Endologix, Inc. | Single puncture bifurcation graft deployment system |
US8034100B2 (en) * | 1999-03-11 | 2011-10-11 | Endologix, Inc. | Graft deployment system |
AU2002230661A1 (en) * | 2000-11-15 | 2002-05-27 | Endologix, Inc. | Implantable vascular graft |
US20030002043A1 (en) * | 2001-04-10 | 2003-01-02 | Kla-Tencor Corporation | Periodic patterns and technique to control misalignment |
US7201940B1 (en) * | 2001-06-12 | 2007-04-10 | Advanced Cardiovascular Systems, Inc. | Method and apparatus for thermal spray processing of medical devices |
AU2002345328A1 (en) | 2001-06-27 | 2003-03-03 | Remon Medical Technologies Ltd. | Method and device for electrochemical formation of therapeutic species in vivo |
US7192484B2 (en) | 2002-09-27 | 2007-03-20 | Surmodics, Inc. | Advanced coating apparatus and method |
US20050131522A1 (en) * | 2003-12-10 | 2005-06-16 | Stinson Jonathan S. | Medical devices and methods of making the same |
US7758892B1 (en) * | 2004-05-20 | 2010-07-20 | Boston Scientific Scimed, Inc. | Medical devices having multiple layers |
CA2573341A1 (en) * | 2004-07-13 | 2006-02-16 | Altairnano, Inc. | Ceramic structures for prevention of drug diversion |
US8263102B2 (en) | 2004-09-28 | 2012-09-11 | Atrium Medical Corporation | Drug delivery coating for use with a stent |
US9012506B2 (en) | 2004-09-28 | 2015-04-21 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
US9000040B2 (en) | 2004-09-28 | 2015-04-07 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
US9801982B2 (en) | 2004-09-28 | 2017-10-31 | Atrium Medical Corporation | Implantable barrier device |
US9801913B2 (en) | 2004-09-28 | 2017-10-31 | Atrium Medical Corporation | Barrier layer |
US20080132994A1 (en) * | 2004-10-08 | 2008-06-05 | Robert Burgermeister | Geometry and non-metallic material for high strength, high flexibility, controlled recoil stent |
US20060127443A1 (en) * | 2004-12-09 | 2006-06-15 | Helmus Michael N | Medical devices having vapor deposited nanoporous coatings for controlled therapeutic agent delivery |
EP1880035B1 (en) * | 2005-05-05 | 2021-01-20 | Höganäs Germany GmbH | Method for coating a substrate surface and coated product |
US20060259126A1 (en) * | 2005-05-05 | 2006-11-16 | Jason Lenz | Medical devices and methods of making the same |
US20070009564A1 (en) * | 2005-06-22 | 2007-01-11 | Mcclain James B | Drug/polymer composite materials and methods of making the same |
US20070038176A1 (en) * | 2005-07-05 | 2007-02-15 | Jan Weber | Medical devices with machined layers for controlled communications with underlying regions |
US20090062909A1 (en) * | 2005-07-15 | 2009-03-05 | Micell Technologies, Inc. | Stent with polymer coating containing amorphous rapamycin |
CN105233349B (en) | 2005-07-15 | 2019-06-18 | 胶束技术股份有限公司 | The polymer coating of drug powder comprising controlled morphology |
JP2009505824A (en) * | 2005-08-23 | 2009-02-12 | アルテアナノ インコーポレイテッド | Advanced photocatalytic phosphorus-doped anatase TiO2 composition and process for its production |
US9427423B2 (en) | 2009-03-10 | 2016-08-30 | Atrium Medical Corporation | Fatty-acid based particles |
US9278161B2 (en) | 2005-09-28 | 2016-03-08 | Atrium Medical Corporation | Tissue-separating fatty acid adhesion barrier |
US20070092591A1 (en) * | 2005-10-24 | 2007-04-26 | Cyberonics, Inc. | Vacuum mandrel for use in fabricating an implantable electrode |
US8840660B2 (en) * | 2006-01-05 | 2014-09-23 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
US8187660B2 (en) * | 2006-01-05 | 2012-05-29 | Howmedica Osteonics Corp. | Method for fabricating a medical implant component and such component |
US8089029B2 (en) * | 2006-02-01 | 2012-01-03 | Boston Scientific Scimed, Inc. | Bioabsorbable metal medical device and method of manufacture |
US20080038482A1 (en) * | 2006-03-02 | 2008-02-14 | Fred Ratel | Method for Low Temperature Production of Nano-Structured Iron Oxide Coatings |
US20080044638A1 (en) * | 2006-03-02 | 2008-02-21 | Fred Ratel | Nanostructured Metal Oxides |
US20080020175A1 (en) * | 2006-03-02 | 2008-01-24 | Fred Ratel | Nanostructured Indium-Doped Iron Oxide |
US8828077B2 (en) * | 2006-03-15 | 2014-09-09 | Medinol Ltd. | Flat process of preparing drug eluting stents |
US20070224244A1 (en) * | 2006-03-22 | 2007-09-27 | Jan Weber | Corrosion resistant coatings for biodegradable metallic implants |
US20070224235A1 (en) * | 2006-03-24 | 2007-09-27 | Barron Tenney | Medical devices having nanoporous coatings for controlled therapeutic agent delivery |
US8187620B2 (en) * | 2006-03-27 | 2012-05-29 | Boston Scientific Scimed, Inc. | Medical devices comprising a porous metal oxide or metal material and a polymer coating for delivering therapeutic agents |
US20070224239A1 (en) * | 2006-03-27 | 2007-09-27 | Niall Behan | Method of making a coated medical device |
US8048150B2 (en) * | 2006-04-12 | 2011-11-01 | Boston Scientific Scimed, Inc. | Endoprosthesis having a fiber meshwork disposed thereon |
CA2650590C (en) | 2006-04-26 | 2018-04-03 | Micell Technologies, Inc. | Coatings containing multiple drugs |
US20070264303A1 (en) * | 2006-05-12 | 2007-11-15 | Liliana Atanasoska | Coating for medical devices comprising an inorganic or ceramic oxide and a therapeutic agent |
US8815275B2 (en) | 2006-06-28 | 2014-08-26 | Boston Scientific Scimed, Inc. | Coatings for medical devices comprising a therapeutic agent and a metallic material |
US8771343B2 (en) * | 2006-06-29 | 2014-07-08 | Boston Scientific Scimed, Inc. | Medical devices with selective titanium oxide coatings |
US20080124373A1 (en) * | 2006-08-02 | 2008-05-29 | Inframat Corporation | Lumen - supporting devices and methods of making and using |
US8052743B2 (en) | 2006-08-02 | 2011-11-08 | Boston Scientific Scimed, Inc. | Endoprosthesis with three-dimensional disintegration control |
CA2662808A1 (en) | 2006-09-14 | 2008-03-20 | Boston Scientific Limited | Medical devices with drug-eluting coating |
EP2210625B8 (en) | 2006-09-15 | 2012-02-29 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis with biostable inorganic layers |
JP2010503494A (en) | 2006-09-15 | 2010-02-04 | ボストン サイエンティフィック リミテッド | Biodegradable endoprosthesis and method for producing the same |
EP2959925B1 (en) * | 2006-09-15 | 2018-08-29 | Boston Scientific Limited | Medical devices and methods of making the same |
US20080071343A1 (en) * | 2006-09-15 | 2008-03-20 | Kevin John Mayberry | Multi-segmented graft deployment system |
CA2663250A1 (en) * | 2006-09-15 | 2008-03-20 | Boston Scientific Limited | Bioerodible endoprostheses and methods of making the same |
CA2663762A1 (en) * | 2006-09-18 | 2008-03-27 | Boston Scientific Limited | Endoprostheses |
WO2008036457A2 (en) * | 2006-09-18 | 2008-03-27 | Boston Scientific Limited | Controlling biodegradation of a medical instrument |
WO2008042909A2 (en) | 2006-10-02 | 2008-04-10 | Micell Technologies Inc. | Surgical sutures having increased strength |
US20080078268A1 (en) * | 2006-10-03 | 2008-04-03 | H.C. Starck Inc. | Process for preparing metal powders having low oxygen content, powders so-produced and uses thereof |
US20080086195A1 (en) * | 2006-10-05 | 2008-04-10 | Boston Scientific Scimed, Inc. | Polymer-Free Coatings For Medical Devices Formed By Plasma Electrolytic Deposition |
CA2667228C (en) | 2006-10-23 | 2015-07-14 | Micell Technologies, Inc. | Holder for electrically charging a substrate during coating |
US9492596B2 (en) | 2006-11-06 | 2016-11-15 | Atrium Medical Corporation | Barrier layer with underlying medical device and one or more reinforcing support structures |
WO2008057344A2 (en) | 2006-11-06 | 2008-05-15 | Atrium Medical Corporation | Coated surgical mesh |
PL2104753T3 (en) * | 2006-11-07 | 2014-12-31 | Starck H C Gmbh | Method for coating a substrate and coated product |
US7981150B2 (en) | 2006-11-09 | 2011-07-19 | Boston Scientific Scimed, Inc. | Endoprosthesis with coatings |
US20080145688A1 (en) | 2006-12-13 | 2008-06-19 | H.C. Starck Inc. | Method of joining tantalum clade steel structures |
ES2506144T3 (en) * | 2006-12-28 | 2014-10-13 | Boston Scientific Limited | Bioerodible endoprosthesis and their manufacturing procedure |
US11426494B2 (en) | 2007-01-08 | 2022-08-30 | MT Acquisition Holdings LLC | Stents having biodegradable layers |
CN101711137B (en) | 2007-01-08 | 2014-10-22 | 米歇尔技术公司 | Stents having biodegradable layers |
US8523931B2 (en) * | 2007-01-12 | 2013-09-03 | Endologix, Inc. | Dual concentric guidewire and methods of bifurcated graft deployment |
US8431149B2 (en) | 2007-03-01 | 2013-04-30 | Boston Scientific Scimed, Inc. | Coated medical devices for abluminal drug delivery |
US8070797B2 (en) | 2007-03-01 | 2011-12-06 | Boston Scientific Scimed, Inc. | Medical device with a porous surface for delivery of a therapeutic agent |
US8067054B2 (en) | 2007-04-05 | 2011-11-29 | Boston Scientific Scimed, Inc. | Stents with ceramic drug reservoir layer and methods of making and using the same |
US20080249600A1 (en) * | 2007-04-06 | 2008-10-09 | Boston Scientific Scimed, Inc. | Stents with drug reservoir layer and methods of making and using the same |
US20080254258A1 (en) * | 2007-04-12 | 2008-10-16 | Altairnano, Inc. | Teflon® replacements and related production methods |
BRPI0810370A2 (en) * | 2007-04-17 | 2014-10-29 | Micell Technologies Inc | STENT COATED, AND METHOD FOR PREPARING A STENT |
AU2015200571B2 (en) * | 2007-04-17 | 2016-11-17 | Micell Technologies, Inc. | Stents having biodegradable layers |
US8197894B2 (en) | 2007-05-04 | 2012-06-12 | H.C. Starck Gmbh | Methods of forming sputtering targets |
US7976915B2 (en) | 2007-05-23 | 2011-07-12 | Boston Scientific Scimed, Inc. | Endoprosthesis with select ceramic morphology |
JP2010527746A (en) | 2007-05-25 | 2010-08-19 | ミセル テクノロジーズ、インコーポレイテッド | Polymer film for medical device coating |
US8133553B2 (en) | 2007-06-18 | 2012-03-13 | Zimmer, Inc. | Process for forming a ceramic layer |
US8309521B2 (en) * | 2007-06-19 | 2012-11-13 | Zimmer, Inc. | Spacer with a coating thereon for use with an implant device |
US7942926B2 (en) | 2007-07-11 | 2011-05-17 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US8002823B2 (en) * | 2007-07-11 | 2011-08-23 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US9284409B2 (en) | 2007-07-19 | 2016-03-15 | Boston Scientific Scimed, Inc. | Endoprosthesis having a non-fouling surface |
US7931683B2 (en) | 2007-07-27 | 2011-04-26 | Boston Scientific Scimed, Inc. | Articles having ceramic coated surfaces |
US8815273B2 (en) * | 2007-07-27 | 2014-08-26 | Boston Scientific Scimed, Inc. | Drug eluting medical devices having porous layers |
WO2009018340A2 (en) * | 2007-07-31 | 2009-02-05 | Boston Scientific Scimed, Inc. | Medical device coating by laser cladding |
JP2010535541A (en) * | 2007-08-03 | 2010-11-25 | ボストン サイエンティフィック リミテッド | Coating for medical devices with large surface area |
US8052745B2 (en) * | 2007-09-13 | 2011-11-08 | Boston Scientific Scimed, Inc. | Endoprosthesis |
US20090093870A1 (en) * | 2007-10-05 | 2009-04-09 | Bacoustics, Llc | Method for Holding a Medical Device During Coating |
US8689728B2 (en) * | 2007-10-05 | 2014-04-08 | Menendez Adolfo | Apparatus for holding a medical device during coating |
US8608049B2 (en) * | 2007-10-10 | 2013-12-17 | Zimmer, Inc. | Method for bonding a tantalum structure to a cobalt-alloy substrate |
US20110230973A1 (en) * | 2007-10-10 | 2011-09-22 | Zimmer, Inc. | Method for bonding a tantalum structure to a cobalt-alloy substrate |
US20100298928A1 (en) * | 2007-10-19 | 2010-11-25 | Micell Technologies, Inc. | Drug Coated Stents |
US20090118809A1 (en) * | 2007-11-02 | 2009-05-07 | Torsten Scheuermann | Endoprosthesis with porous reservoir and non-polymer diffusion layer |
US20090118813A1 (en) * | 2007-11-02 | 2009-05-07 | Torsten Scheuermann | Nano-patterned implant surfaces |
US20090118812A1 (en) * | 2007-11-02 | 2009-05-07 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US8029554B2 (en) * | 2007-11-02 | 2011-10-04 | Boston Scientific Scimed, Inc. | Stent with embedded material |
US20090118815A1 (en) * | 2007-11-02 | 2009-05-07 | Boston Scientific Scimed, Inc. | Stent |
US7938855B2 (en) | 2007-11-02 | 2011-05-10 | Boston Scientific Scimed, Inc. | Deformable underlayer for stent |
US8216632B2 (en) | 2007-11-02 | 2012-07-10 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US20090118821A1 (en) * | 2007-11-02 | 2009-05-07 | Boston Scientific Scimed, Inc. | Endoprosthesis with porous reservoir and non-polymer diffusion layer |
US8221821B1 (en) | 2007-11-09 | 2012-07-17 | Abbott Cardiovascular Systems Inc. | Methods of modifying ablumenal/lumenal stent coating thicknesses |
US7833266B2 (en) * | 2007-11-28 | 2010-11-16 | Boston Scientific Scimed, Inc. | Bifurcated stent with drug wells for specific ostial, carina, and side branch treatment |
US20090143855A1 (en) * | 2007-11-29 | 2009-06-04 | Boston Scientific Scimed, Inc. | Medical Device Including Drug-Loaded Fibers |
US20100008970A1 (en) * | 2007-12-14 | 2010-01-14 | Boston Scientific Scimed, Inc. | Drug-Eluting Endoprosthesis |
US20090187256A1 (en) * | 2008-01-21 | 2009-07-23 | Zimmer, Inc. | Method for forming an integral porous region in a cast implant |
US8221494B2 (en) | 2008-02-22 | 2012-07-17 | Endologix, Inc. | Apparatus and method of placement of a graft or graft system |
WO2009109016A1 (en) * | 2008-03-06 | 2009-09-11 | Commonwealth Scientific And Industrial Research Organisation | Manufacture of pipes |
US8236040B2 (en) | 2008-04-11 | 2012-08-07 | Endologix, Inc. | Bifurcated graft deployment systems and methods |
CN102083397B (en) | 2008-04-17 | 2013-12-25 | 米歇尔技术公司 | Stents having bioabsorbable layers |
EP2271380B1 (en) | 2008-04-22 | 2013-03-20 | Boston Scientific Scimed, Inc. | Medical devices having a coating of inorganic material |
WO2009132176A2 (en) | 2008-04-24 | 2009-10-29 | Boston Scientific Scimed, Inc. | Medical devices having inorganic particle layers |
US7998192B2 (en) * | 2008-05-09 | 2011-08-16 | Boston Scientific Scimed, Inc. | Endoprostheses |
US8236046B2 (en) | 2008-06-10 | 2012-08-07 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis |
EP2303350A2 (en) | 2008-06-18 | 2011-04-06 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
EP2520320B1 (en) | 2008-07-01 | 2016-11-02 | Endologix, Inc. | Catheter system |
US20100004733A1 (en) * | 2008-07-02 | 2010-01-07 | Boston Scientific Scimed, Inc. | Implants Including Fractal Structures |
WO2010009335A1 (en) | 2008-07-17 | 2010-01-21 | Micell Technologies, Inc. | Drug delivery medical device |
US7951193B2 (en) * | 2008-07-23 | 2011-05-31 | Boston Scientific Scimed, Inc. | Drug-eluting stent |
US7985252B2 (en) * | 2008-07-30 | 2011-07-26 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis |
US8246903B2 (en) | 2008-09-09 | 2012-08-21 | H.C. Starck Inc. | Dynamic dehydriding of refractory metal powders |
US8382824B2 (en) * | 2008-10-03 | 2013-02-26 | Boston Scientific Scimed, Inc. | Medical implant having NANO-crystal grains with barrier layers of metal nitrides or fluorides |
CN105355415A (en) * | 2008-11-06 | 2016-02-24 | 因太金属株式会社 | Method for producing rare earth sintered magnet and powder container for rare earth sintered magnet production |
US8231980B2 (en) * | 2008-12-03 | 2012-07-31 | Boston Scientific Scimed, Inc. | Medical implants including iridium oxide |
EP2199423B1 (en) * | 2008-12-16 | 2013-04-17 | Sulzer Metco AG | Thermally injected surface layer and orthopaedic implant |
CN102084019A (en) * | 2008-12-17 | 2011-06-01 | 高标国际有限公司 | Antibacterial coating, its preparation methods and metalwork containing the coating |
US8834913B2 (en) | 2008-12-26 | 2014-09-16 | Battelle Memorial Institute | Medical implants and methods of making medical implants |
US8267992B2 (en) * | 2009-03-02 | 2012-09-18 | Boston Scientific Scimed, Inc. | Self-buffering medical implants |
US8071156B2 (en) * | 2009-03-04 | 2011-12-06 | Boston Scientific Scimed, Inc. | Endoprostheses |
EP2411083A4 (en) * | 2009-03-23 | 2013-11-13 | Micell Technologies Inc | Drug delivery medical device |
US20100241220A1 (en) * | 2009-03-23 | 2010-09-23 | Mcclain James B | Peripheral Stents Having Layers |
WO2010111238A2 (en) * | 2009-03-23 | 2010-09-30 | Micell Technologies, Inc. | Improved biodegradable polymers |
WO2010120552A2 (en) | 2009-04-01 | 2010-10-21 | Micell Technologies, Inc. | Coated stents |
EP3366326A1 (en) | 2009-04-17 | 2018-08-29 | Micell Technologies, Inc. | Stents having controlled elution |
US8287937B2 (en) * | 2009-04-24 | 2012-10-16 | Boston Scientific Scimed, Inc. | Endoprosthese |
US20100274352A1 (en) * | 2009-04-24 | 2010-10-28 | Boston Scientific Scrimed, Inc. | Endoprosthesis with Selective Drug Coatings |
US20110054586A1 (en) * | 2009-04-28 | 2011-03-03 | Endologix, Inc. | Apparatus and method of placement of a graft or graft system |
US10772717B2 (en) | 2009-05-01 | 2020-09-15 | Endologix, Inc. | Percutaneous method and device to treat dissections |
JP2012525239A (en) * | 2009-05-01 | 2012-10-22 | エンドロジックス、インク | Transcutaneous methods and devices for treating dissociation (priority information and incorporation by reference) |
US8709467B2 (en) | 2009-06-26 | 2014-04-29 | Cute Lovable Teddy Bear, Llc. | Para-xylylene based microfilm elution devices |
WO2011008989A2 (en) | 2009-07-15 | 2011-01-20 | Endologix, Inc. | Stent graft |
EP2453834A4 (en) | 2009-07-16 | 2014-04-16 | Micell Technologies Inc | Drug delivery medical device |
US20110022158A1 (en) * | 2009-07-22 | 2011-01-27 | Boston Scientific Scimed, Inc. | Bioerodible Medical Implants |
ES2549000T3 (en) | 2009-07-27 | 2015-10-22 | Endologix, Inc. | Endoprosthesis |
US20110038910A1 (en) | 2009-08-11 | 2011-02-17 | Atrium Medical Corporation | Anti-infective antimicrobial-containing biomaterials |
DE102009037894A1 (en) * | 2009-08-18 | 2011-02-24 | Mtu Aero Engines Gmbh | Thin-walled structural component and method for its production |
US20110071633A1 (en) * | 2009-09-23 | 2011-03-24 | Mx Orthopedics Corp. | Coating a Shape-Memory Prosthesis |
DE102009052946A1 (en) | 2009-11-12 | 2011-05-19 | Mtu Aero Engines Gmbh | Method and device for component coating |
WO2011097103A1 (en) | 2010-02-02 | 2011-08-11 | Micell Technologies, Inc. | Stent and stent delivery system with improved deliverability |
US9109292B2 (en) * | 2010-02-25 | 2015-08-18 | Polyprotec Technologies | Anti-microbial coated devices and methods for making same |
US20110218617A1 (en) * | 2010-03-02 | 2011-09-08 | Endologix, Inc. | Endoluminal vascular prosthesis |
US8668732B2 (en) * | 2010-03-23 | 2014-03-11 | Boston Scientific Scimed, Inc. | Surface treated bioerodible metal endoprostheses |
US8795762B2 (en) | 2010-03-26 | 2014-08-05 | Battelle Memorial Institute | System and method for enhanced electrostatic deposition and surface coatings |
CA2797110C (en) | 2010-04-22 | 2020-07-21 | Micell Technologies, Inc. | Stents and other devices having extracellular matrix coating |
US9328918B2 (en) | 2010-05-28 | 2016-05-03 | General Electric Company | Combustion cold spray |
WO2012009707A2 (en) | 2010-07-16 | 2012-01-19 | Atrium Medical Corporation | Composition and methods for altering the rate of hydrolysis of cured oil-based materials |
CA2805631C (en) | 2010-07-16 | 2018-07-31 | Micell Technologies, Inc. | Drug delivery medical device |
US9023121B2 (en) * | 2010-10-20 | 2015-05-05 | Alliant Techsystems Inc. | Solid feed systems for elevated pressure processes, gasification systems and related methods |
US20120109279A1 (en) | 2010-11-02 | 2012-05-03 | Endologix, Inc. | Apparatus and method of placement of a graft or graft system |
WO2012068298A1 (en) | 2010-11-17 | 2012-05-24 | Endologix, Inc. | Devices and methods to treat vascular dissections |
EP2680915B1 (en) | 2011-03-01 | 2021-12-22 | Endologix LLC | Catheter system |
JP5712054B2 (en) * | 2011-05-31 | 2015-05-07 | 日本発條株式会社 | Heater unit with shaft and manufacturing method of heater unit with shaft |
US10464100B2 (en) | 2011-05-31 | 2019-11-05 | Micell Technologies, Inc. | System and process for formation of a time-released, drug-eluting transferable coating |
US10117972B2 (en) | 2011-07-15 | 2018-11-06 | Micell Technologies, Inc. | Drug delivery medical device |
US9120183B2 (en) | 2011-09-29 | 2015-09-01 | H.C. Starck Inc. | Methods of manufacturing large-area sputtering targets |
US9381112B1 (en) | 2011-10-06 | 2016-07-05 | William Eric Sponsell | Bleb drainage device, ophthalmological product and methods |
US10188772B2 (en) | 2011-10-18 | 2019-01-29 | Micell Technologies, Inc. | Drug delivery medical device |
US8475882B2 (en) | 2011-10-19 | 2013-07-02 | General Electric Company | Titanium aluminide application process and article with titanium aluminide surface |
US20130156935A1 (en) * | 2011-12-14 | 2013-06-20 | Rachit Ohri | Methods for Coating Medical Devices |
US8632489B1 (en) | 2011-12-22 | 2014-01-21 | A. Mateen Ahmed | Implantable medical assembly and methods |
US10736995B2 (en) | 2012-05-02 | 2020-08-11 | Les Entreprises Nanostent Inc. | Bioresorbable medical devices and method of manufacturing the same |
US10028847B2 (en) | 2012-05-02 | 2018-07-24 | Les Enterprises Nanostent Inc. | Bioresorbable medical devices and method of manufacturing the same |
US9334565B2 (en) * | 2012-05-09 | 2016-05-10 | H.C. Starck Inc. | Multi-block sputtering target with interface portions and associated methods and articles |
US9867880B2 (en) * | 2012-06-13 | 2018-01-16 | Atrium Medical Corporation | Cured oil-hydrogel biomaterial compositions for controlled drug delivery |
US9335296B2 (en) | 2012-10-10 | 2016-05-10 | Westinghouse Electric Company Llc | Systems and methods for steam generator tube analysis for detection of tube degradation |
RU2513623C1 (en) * | 2012-11-14 | 2014-04-20 | Евгений Александрович Лебедев | Superdispersed powder production plant |
CN102961787B (en) * | 2012-12-13 | 2015-06-03 | 北京大学 | Iron-based composite material used for full-degradation cardiovascular support and preparation method thereof |
CA2903188A1 (en) * | 2013-03-05 | 2014-09-12 | Pcc Structurals Inc. | Bonding of titanium coating to cast cocr |
KR20150143476A (en) | 2013-03-12 | 2015-12-23 | 미셀 테크놀로지즈, 인코포레이티드 | Bioabsorbable biomedical implants |
US9771613B2 (en) | 2013-04-02 | 2017-09-26 | Molecular Assemblies, Inc. | Methods and apparatus for synthesizing nucleic acid |
US10683536B2 (en) | 2013-04-02 | 2020-06-16 | Molecular Assemblies, Inc. | Reusable initiators for synthesizing nucleic acids |
US9279149B2 (en) | 2013-04-02 | 2016-03-08 | Molecular Assemblies, Inc. | Methods and apparatus for synthesizing nucleic acids |
US11384377B2 (en) | 2013-04-02 | 2022-07-12 | Molecular Assemblies, Inc. | Reusable initiators for synthesizing nucleic acids |
US11331643B2 (en) | 2013-04-02 | 2022-05-17 | Molecular Assemblies, Inc. | Reusable initiators for synthesizing nucleic acids |
US8808989B1 (en) | 2013-04-02 | 2014-08-19 | Molecular Assemblies, Inc. | Methods and apparatus for synthesizing nucleic acids |
US9566071B2 (en) | 2013-04-11 | 2017-02-14 | Blockade Medical, LLC | Systems and devices for cerebral aneurysm repair |
WO2014169261A1 (en) * | 2013-04-11 | 2014-10-16 | Blockade Medical, LLC | Radiopaque devices for cerebral aneurysm repair |
WO2014186532A1 (en) | 2013-05-15 | 2014-11-20 | Micell Technologies, Inc. | Bioabsorbable biomedical implants |
DE102013014821A1 (en) * | 2013-09-10 | 2015-03-12 | Alexander Rübben | Gefäßendoprothesenbeschichtung |
US9675478B2 (en) | 2014-06-11 | 2017-06-13 | Abbott Cardiovascular Systems Inc. | Solvent method for forming a polymer scaffolding |
US9381280B2 (en) | 2014-06-13 | 2016-07-05 | Abbott Cardiovascular Systems Inc. | Plasticizers for a biodegradable scaffolding and methods of forming same |
US11274362B2 (en) | 2014-08-29 | 2022-03-15 | Toufic Azar | Bioresorbable materials, bioresorbable medical devices, bioresorbable coatings for implantable medical devices and method of manufacturing the same using vapor deposition |
CA2984429A1 (en) * | 2015-06-29 | 2017-01-05 | Oerlikon Metco (Us) Inc. | Cold gas spray coating methods and compositions |
EP3139860B1 (en) | 2015-06-30 | 2024-06-12 | Endologix LLC | Locking assembly for coupling guidewire to delivery system |
US11519075B2 (en) | 2016-05-05 | 2022-12-06 | National Research Council Of Canada | Porous metal coatings using shockwave induced spraying |
CN108500275B (en) * | 2018-04-18 | 2019-11-26 | 西安交通大学 | A kind of part increasing material manufacturing device and method of high-compactness and low residual stress |
CN108705085B (en) * | 2018-06-01 | 2020-01-14 | 佛山市南海区广工大数控装备协同创新研究院 | Three-dimensional printer |
JP7206716B2 (en) * | 2018-09-07 | 2023-01-18 | トヨタ自動車株式会社 | Evaporator, manufacturing method thereof, and loop heat pipe having evaporator |
US11935662B2 (en) | 2019-07-02 | 2024-03-19 | Westinghouse Electric Company Llc | Elongate SiC fuel elements |
WO2021055284A1 (en) | 2019-09-19 | 2021-03-25 | Westinghouse Electric Company Llc | Apparatus for performing in-situ adhesion test of cold spray deposits and method of employing |
CN111299085B (en) * | 2020-03-26 | 2022-10-04 | 苏州微比特自动化有限公司 | Online dip-coating curing device |
CN111420841A (en) * | 2020-03-26 | 2020-07-17 | 苏州微比特自动化有限公司 | Online dip-coating device |
CN113529065B (en) * | 2020-04-16 | 2022-11-08 | 中国科学院金属研究所 | Method and device for preparing iridium metal coating based on cold spraying high-speed deposition additive manufacturing technology |
CN114686871B (en) * | 2022-03-30 | 2023-07-25 | 中国兵器科学研究院宁波分院 | Preparation method of biological porous coating based on powder oxygenation design |
Citations (99)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3657744A (en) * | 1970-05-08 | 1972-04-25 | Univ Minnesota | Method for fixing prosthetic implants in a living body |
US4140126A (en) * | 1977-02-18 | 1979-02-20 | Choudhury M Hasan | Method for performing aneurysm repair |
US4503569A (en) * | 1983-03-03 | 1985-03-12 | Dotter Charles T | Transluminally placed expandable graft prosthesis |
US4512338A (en) * | 1983-01-25 | 1985-04-23 | Balko Alexander B | Process for restoring patency to body vessels |
US4580568A (en) * | 1984-10-01 | 1986-04-08 | Cook, Incorporated | Percutaneous endovascular stent and method for insertion thereof |
US4633873A (en) * | 1984-04-26 | 1987-01-06 | American Cyanamid Company | Surgical repair mesh |
US4650466A (en) * | 1985-11-01 | 1987-03-17 | Angiobrade Partners | Angioplasty device |
US4649922A (en) * | 1986-01-23 | 1987-03-17 | Wiktor Donimik M | Catheter arrangement having a variable diameter tip and spring prosthesis |
US4656083A (en) * | 1983-08-01 | 1987-04-07 | Washington Research Foundation | Plasma gas discharge treatment for improving the biocompatibility of biomaterials |
US4655771A (en) * | 1982-04-30 | 1987-04-07 | Shepherd Patents S.A. | Prosthesis comprising an expansible or contractile tubular body |
US4718907A (en) * | 1985-06-20 | 1988-01-12 | Atrium Medical Corporation | Vascular prosthesis having fluorinated coating with varying F/C ratio |
US4722335A (en) * | 1986-10-20 | 1988-02-02 | Vilasi Joseph A | Expandable endotracheal tube |
US4723549A (en) * | 1986-09-18 | 1988-02-09 | Wholey Mark H | Method and apparatus for dilating blood vessels |
US4728328A (en) * | 1984-10-19 | 1988-03-01 | Research Corporation | Cuffed tubular organic prostheses |
US4740207A (en) * | 1986-09-10 | 1988-04-26 | Kreamer Jeffry W | Intralumenal graft |
US4739762A (en) * | 1985-11-07 | 1988-04-26 | Expandable Grafts Partnership | Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft |
US4800882A (en) * | 1987-03-13 | 1989-01-31 | Cook Incorporated | Endovascular stent and delivery system |
US4816339A (en) * | 1987-04-28 | 1989-03-28 | Baxter International Inc. | Multi-layered poly(tetrafluoroethylene)/elastomer materials useful for in vivo implantation |
US4892539A (en) * | 1988-02-08 | 1990-01-09 | D-R Medical Systems, Inc. | Vascular graft |
US4893623A (en) * | 1986-12-09 | 1990-01-16 | Advanced Surgical Intervention, Inc. | Method and apparatus for treating hypertrophy of the prostate gland |
US4907336A (en) * | 1987-03-13 | 1990-03-13 | Cook Incorporated | Method of making an endovascular stent and delivery system |
US4913141A (en) * | 1988-10-25 | 1990-04-03 | Cordis Corporation | Apparatus and method for placement of a stent within a subject vessel |
US4922905A (en) * | 1985-11-30 | 1990-05-08 | Strecker Ernst P | Dilatation catheter |
US4981478A (en) * | 1988-09-06 | 1991-01-01 | Advanced Cardiovascular Systems | Composite vascular catheter |
US4986831A (en) * | 1988-04-25 | 1991-01-22 | Angeion Corporation | Medical implant |
US4990155A (en) * | 1989-05-19 | 1991-02-05 | Wilkoff Howard M | Surgical stent method and apparatus |
US4994298A (en) * | 1988-06-07 | 1991-02-19 | Biogold Inc. | Method of making a biocompatible prosthesis |
US4994071A (en) * | 1989-05-22 | 1991-02-19 | Cordis Corporation | Bifurcating stent apparatus and method |
US4998539A (en) * | 1987-12-18 | 1991-03-12 | Delsanti Gerard L | Method of using removable endo-arterial devices to repair detachments in the arterial walls |
US5002560A (en) * | 1989-09-08 | 1991-03-26 | Advanced Cardiovascular Systems, Inc. | Expandable cage catheter with a rotatable guide |
US5007926A (en) * | 1989-02-24 | 1991-04-16 | The Trustees Of The University Of Pennsylvania | Expandable transluminally implantable tubular prosthesis |
US5015253A (en) * | 1989-06-15 | 1991-05-14 | Cordis Corporation | Non-woven endoprosthesis |
US5078720A (en) * | 1990-05-02 | 1992-01-07 | American Medical Systems, Inc. | Stent placement instrument and method |
US5078736A (en) * | 1990-05-04 | 1992-01-07 | Interventional Thermodynamics, Inc. | Method and apparatus for maintaining patency in the body passages |
US5078726A (en) * | 1989-02-01 | 1992-01-07 | Kreamer Jeffry W | Graft stent and method of repairing blood vessels |
US5084065A (en) * | 1989-07-10 | 1992-01-28 | Corvita Corporation | Reinforced graft assembly |
US5085629A (en) * | 1988-10-06 | 1992-02-04 | Medical Engineering Corporation | Biodegradable stent |
US5089005A (en) * | 1987-08-13 | 1992-02-18 | Terumo Kabushiki Kaisha | Catheter for the introduction of an expandable member |
US5092877A (en) * | 1988-09-01 | 1992-03-03 | Corvita Corporation | Radially expandable endoprosthesis |
US5100429A (en) * | 1989-04-28 | 1992-03-31 | C. R. Bard, Inc. | Endovascular stent and delivery system |
US5102417A (en) * | 1985-11-07 | 1992-04-07 | Expandable Grafts Partnership | Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft |
US5108755A (en) * | 1989-04-27 | 1992-04-28 | Sri International | Biodegradable composites for internal medical use |
US5108416A (en) * | 1990-02-13 | 1992-04-28 | C. R. Bard, Inc. | Stent introducer system |
US5108417A (en) * | 1990-09-14 | 1992-04-28 | Interface Biomedical Laboratories Corp. | Anti-turbulent, anti-thrombogenic intravascular stent |
US5107852A (en) * | 1990-04-02 | 1992-04-28 | W. L. Gore & Associates, Inc. | Catheter guidewire device having a covering of fluoropolymer tape |
US5176661A (en) * | 1988-09-06 | 1993-01-05 | Advanced Cardiovascular Systems, Inc. | Composite vascular catheter |
US5183085A (en) * | 1991-09-27 | 1993-02-02 | Hans Timmermans | Method and apparatus for compressing a stent prior to insertion |
US5192311A (en) * | 1988-04-25 | 1993-03-09 | Angeion Corporation | Medical implant and method of making |
US5192307A (en) * | 1987-12-08 | 1993-03-09 | Wall W Henry | Angioplasty stent |
US5192297A (en) * | 1991-12-31 | 1993-03-09 | Medtronic, Inc. | Apparatus and method for placement and implantation of a stent |
US5197977A (en) * | 1984-01-30 | 1993-03-30 | Meadox Medicals, Inc. | Drug delivery collagen-impregnated synthetic vascular graft |
US5206341A (en) * | 1991-11-21 | 1993-04-27 | Southern Research Institute | Polymers from hydroxy acids and polycarboxylic acids |
US5279594A (en) * | 1990-05-23 | 1994-01-18 | Jackson Richard R | Intubation devices with local anesthetic effect for medical use |
US5282860A (en) * | 1991-10-16 | 1994-02-01 | Olympus Optical Co., Ltd. | Stent tube for medical use |
US5282823A (en) * | 1992-03-19 | 1994-02-01 | Medtronic, Inc. | Intravascular radially expandable stent |
US5289831A (en) * | 1989-03-09 | 1994-03-01 | Vance Products Incorporated | Surface-treated stent, catheter, cannula, and the like |
US5290271A (en) * | 1990-05-14 | 1994-03-01 | Jernberg Gary R | Surgical implant and method for controlled release of chemotherapeutic agents |
US5290230A (en) * | 1992-05-11 | 1994-03-01 | Advanced Cardiovascular Systems, Inc. | Intraluminal catheter with a composite shaft |
US5302414A (en) * | 1990-05-19 | 1994-04-12 | Anatoly Nikiforovich Papyrin | Gas-dynamic spraying method for applying a coating |
US5304200A (en) * | 1991-05-29 | 1994-04-19 | Cordis Corporation | Welded radially expandable endoprosthesis and the like |
US5306286A (en) * | 1987-06-25 | 1994-04-26 | Duke University | Absorbable stent |
US5383927A (en) * | 1992-05-07 | 1995-01-24 | Intervascular Inc. | Non-thromogenic vascular prosthesis |
US5389106A (en) * | 1993-10-29 | 1995-02-14 | Numed, Inc. | Impermeable expandable intravascular stent |
US5601538A (en) * | 1995-03-07 | 1997-02-11 | Medtronic, Inc. | Flow directed catheter with hydrophilic distal end |
US5601593A (en) * | 1995-03-06 | 1997-02-11 | Willy Rusch Ag | Stent for placement in a body tube |
US5603991A (en) * | 1995-09-29 | 1997-02-18 | Target Therapeutics, Inc. | Method for coating catheter lumens |
US5607442A (en) * | 1995-11-13 | 1997-03-04 | Isostent, Inc. | Stent with improved radiopacity and appearance characteristics |
US5609629A (en) * | 1995-06-07 | 1997-03-11 | Med Institute, Inc. | Coated implantable medical device |
US5618298A (en) * | 1993-10-23 | 1997-04-08 | Simon; Michael | Vascular prosthesis made of resorbable material |
US5624411A (en) * | 1993-04-26 | 1997-04-29 | Medtronic, Inc. | Intravascular stent and method |
US5707388A (en) * | 1994-12-09 | 1998-01-13 | Intervascular, Inc. | High hoop strength intraluminal stent |
US5713949A (en) * | 1996-08-06 | 1998-02-03 | Jayaraman; Swaminathan | Microporous covered stents and method of coating |
US5716406A (en) * | 1991-12-06 | 1998-02-10 | North Shore University Hospital Research Corp. | Method of reducing medical device related infections |
US5718723A (en) * | 1994-03-15 | 1998-02-17 | Seikagaku Kogyo Kabushiki Kaisha (Seikagaku Corporation) | Artificial blood vessel and process for producing the same |
US5718726A (en) * | 1995-09-12 | 1998-02-17 | Biotronik Mess- und Therapiegerate GmbH & Co | Method of attaching heparin to, and immobilizing it on, inorganic substrate surfaces of cardiovascular implants |
US5725672A (en) * | 1984-02-13 | 1998-03-10 | Jet Process Corporation | Apparatus for the high speed, low pressure gas jet deposition of conducting and dielectric thin sold films |
US5730733A (en) * | 1995-06-01 | 1998-03-24 | Scimed Life Systems, Inc. | Flow assisted catheter |
US5735892A (en) * | 1993-08-18 | 1998-04-07 | W. L. Gore & Associates, Inc. | Intraluminal stent graft |
US5741327A (en) * | 1997-05-06 | 1998-04-21 | Global Therapeutics, Inc. | Surgical stent featuring radiopaque markers |
US5868783A (en) * | 1997-04-16 | 1999-02-09 | Numed, Inc. | Intravascular stent with limited axial shrinkage |
US5869127A (en) * | 1995-02-22 | 1999-02-09 | Boston Scientific Corporation | Method of providing a substrate with a bio-active/biocompatible coating |
US6010529A (en) * | 1996-12-03 | 2000-01-04 | Atrium Medical Corporation | Expandable shielded vessel support |
US6010530A (en) * | 1995-06-07 | 2000-01-04 | Boston Scientific Technology, Inc. | Self-expanding endoluminal prosthesis |
US6010521A (en) * | 1997-11-25 | 2000-01-04 | Advanced Cardiovasular Systems, Inc. | Catheter member with bondable layer |
US6013100A (en) * | 1995-05-19 | 2000-01-11 | Inoue; Kanji | Appliance to be implanted, method of collapsing the appliance to be implanted and method of using the appliance to be implanted |
US6015430A (en) * | 1987-12-08 | 2000-01-18 | Wall; William H. | Expandable stent having a fabric liner |
US6015429A (en) * | 1994-09-08 | 2000-01-18 | Gore Enterprise Holdings, Inc. | Procedures for introducing stents and stent-grafts |
US6019789A (en) * | 1998-04-01 | 2000-02-01 | Quanam Medical Corporation | Expandable unit cell and intraluminal stent |
US6025034A (en) * | 1995-11-13 | 2000-02-15 | University Of Connecticut And Rutgers | Method of manufacture of nanostructured feeds |
US6027526A (en) * | 1996-04-10 | 2000-02-22 | Advanced Cardiovascular Systems, Inc. | Stent having varied amounts of structural strength along its length |
US6042597A (en) * | 1998-10-23 | 2000-03-28 | Scimed Life Systems, Inc. | Helical stent design |
US6168619B1 (en) * | 1998-10-16 | 2001-01-02 | Quanam Medical Corporation | Intravascular stent having a coaxial polymer member and end sleeves |
US6174330B1 (en) * | 1997-08-01 | 2001-01-16 | Schneider (Usa) Inc | Bioabsorbable marker having radiopaque constituents |
US6184266B1 (en) * | 1996-07-11 | 2001-02-06 | Scimed Life Systems, Inc. | Medical devices comprising cross-linked hydrogels having improved mechanical properties |
US20020032477A1 (en) * | 1995-04-19 | 2002-03-14 | Michael N. Helmus | Drug release coated stent |
US6358531B1 (en) * | 1999-02-01 | 2002-03-19 | The Curators Of The University Of Missouri | Method for preparing porous shells or gels from glass particles |
US6368658B1 (en) * | 1999-04-19 | 2002-04-09 | Scimed Life Systems, Inc. | Coating medical devices using air suspension |
US20020042645A1 (en) * | 1996-07-03 | 2002-04-11 | Shannon Donald T. | Drug eluting radially expandable tubular stented grafts |
US6502767B2 (en) * | 2000-05-03 | 2003-01-07 | Asb Industries | Advanced cold spray system |
Family Cites Families (72)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3105492A (en) | 1958-10-01 | 1963-10-01 | Us Catheter & Instr Corp | Synthetic blood vessel grafts |
US3288728A (en) | 1966-02-18 | 1966-11-29 | Union Carbide Corp | Para-xylylene copolymers |
US3605123A (en) * | 1969-04-29 | 1971-09-20 | Melpar Inc | Bone implant |
US3839743A (en) | 1972-04-21 | 1974-10-08 | A Schwarcz | Method for maintaining the normal integrity of blood |
SE397769B (en) | 1974-11-04 | 1977-11-21 | Gambro Ab | INITIATIVE ELEMENTS FOR USE IN VEHICLE SURGERY AND METHODS OF PRODUCING SUCCESSFUL |
US4159719A (en) | 1977-05-09 | 1979-07-03 | Xomed, Inc. | Moisture-expandable ear wick |
US4130904A (en) | 1977-06-06 | 1978-12-26 | Thermo Electron Corporation | Prosthetic blood conduit |
US4346028A (en) | 1979-12-14 | 1982-08-24 | Monsanto Company | Asbestiform crystalline calcium sodium or lithium phosphate, preparation and compositions |
US4411055A (en) | 1980-05-19 | 1983-10-25 | Advanced Cardiovascular Systems, Inc. | Vascular guiding catheter assembly and vascular dilating catheter assembly and a combination thereof and methods for making the same |
US4604762A (en) | 1981-02-13 | 1986-08-12 | Thoratec Laboratories Corporation | Arterial graft prosthesis |
US4553545A (en) | 1981-09-16 | 1985-11-19 | Medinvent S.A. | Device for application in blood vessels or other difficultly accessible locations and its use |
US4542539A (en) * | 1982-03-12 | 1985-09-24 | Artech Corp. | Surgical implant having a graded porous coating |
US4531933A (en) | 1982-12-07 | 1985-07-30 | C. R. Bard, Inc. | Helical ureteral stent |
CH663219A5 (en) * | 1984-01-31 | 1987-11-30 | Castolin Sa | FLAME INJECTION MATERIAL. |
DK151404C (en) | 1984-05-23 | 1988-07-18 | Cook Europ Aps William | FULLY FILTER FOR IMPLANTATION IN A PATIENT'S BLOOD |
US4879135A (en) | 1984-07-23 | 1989-11-07 | University Of Medicine And Dentistry Of New Jersey | Drug bonded prosthesis and process for producing same |
US5037377A (en) | 1984-11-28 | 1991-08-06 | Medtronic, Inc. | Means for improving biocompatibility of implants, particularly of vascular grafts |
US4699611A (en) | 1985-04-19 | 1987-10-13 | C. R. Bard, Inc. | Biliary stent introducer |
US4706671A (en) | 1985-05-02 | 1987-11-17 | Weinrib Harry P | Catheter with coiled tip |
US4681110A (en) | 1985-12-02 | 1987-07-21 | Wiktor Dominik M | Catheter arrangement having a blood vessel liner, and method of using it |
US4878906A (en) | 1986-03-25 | 1989-11-07 | Servetus Partnership | Endoprosthesis for repairing a damaged vessel |
SE453258B (en) | 1986-04-21 | 1988-01-25 | Medinvent Sa | ELASTIC, SELF-EXPANDING PROTEST AND PROCEDURE FOR ITS MANUFACTURING |
US4800822A (en) | 1986-10-09 | 1989-01-31 | John Adkins | Gun safe with ejectable drawer |
SE455834B (en) | 1986-10-31 | 1988-08-15 | Medinvent Sa | DEVICE FOR TRANSLUMINAL IMPLANTATION OF A PRINCIPLE RODFORMALLY RADIALLY EXPANDABLE PROSTHESIS |
US4762128A (en) | 1986-12-09 | 1988-08-09 | Advanced Surgical Intervention, Inc. | Method and apparatus for treating hypertrophy of the prostate gland |
IT1202558B (en) | 1987-02-17 | 1989-02-09 | Alberto Arpesani | INTERNAL PROSTHESIS FOR THE REPLACEMENT OF A PART OF THE HUMAN BODY PARTICULARLY IN THE VASCULAR OPERATIONS |
US5041126A (en) | 1987-03-13 | 1991-08-20 | Cook Incorporated | Endovascular stent and delivery system |
JPS63238872A (en) | 1987-03-25 | 1988-10-04 | テルモ株式会社 | Instrument for securing inner diameter of cavity of tubular organ and catheter equipped therewith |
US4969458A (en) | 1987-07-06 | 1990-11-13 | Medtronic, Inc. | Intracoronary stent and method of simultaneous angioplasty and stent implant |
JPH088933B2 (en) | 1987-07-10 | 1996-01-31 | 日本ゼオン株式会社 | Catheter |
US4886062A (en) | 1987-10-19 | 1989-12-12 | Medtronic, Inc. | Intravascular radially expandable stent and method of implant |
US5133732A (en) | 1987-10-19 | 1992-07-28 | Medtronic, Inc. | Intravascular stent |
US4870966A (en) | 1988-02-01 | 1989-10-03 | American Cyanamid Company | Bioabsorbable surgical device for treating nerve defects |
US4877030A (en) | 1988-02-02 | 1989-10-31 | Andreas Beck | Device for the widening of blood vessels |
US5053048A (en) | 1988-09-22 | 1991-10-01 | Cordis Corporation | Thromboresistant coating |
US4943346A (en) | 1988-09-29 | 1990-07-24 | Siemens Aktiengesellschaft | Method for manufacturing printed circuit boards |
US5019085A (en) | 1988-10-25 | 1991-05-28 | Cordis Corporation | Apparatus and method for placement of a stent within a subject vessel |
US4950227A (en) | 1988-11-07 | 1990-08-21 | Boston Scientific Corporation | Stent delivery system |
US4856516A (en) | 1989-01-09 | 1989-08-15 | Cordis Corporation | Endovascular stent apparatus and method |
NZ228382A (en) | 1989-03-17 | 1992-08-26 | Carter Holt Harvey Plastic Pro | Drug administering coil-like device for insertion in body cavity of animal |
US5037392A (en) | 1989-06-06 | 1991-08-06 | Cordis Corporation | Stent-implanting balloon assembly |
US5116318A (en) | 1989-06-06 | 1992-05-26 | Cordis Corporation | Dilatation balloon within an elastic sleeve |
EP0408245B1 (en) | 1989-07-13 | 1994-03-02 | American Medical Systems, Inc. | Stent placement instrument |
US5034001A (en) | 1989-09-08 | 1991-07-23 | Advanced Cardiovascular Systems, Inc. | Method of repairing a damaged blood vessel with an expandable cage catheter |
US5035706A (en) | 1989-10-17 | 1991-07-30 | Cook Incorporated | Percutaneous stent and method for retrieval thereof |
US5135516A (en) | 1989-12-15 | 1992-08-04 | Boston Scientific Corporation | Lubricious antithrombogenic catheters, guidewires and coatings |
US5477864A (en) * | 1989-12-21 | 1995-12-26 | Smith & Nephew Richards, Inc. | Cardiovascular guidewire of enhanced biocompatibility |
US5071407A (en) | 1990-04-12 | 1991-12-10 | Schneider (U.S.A.) Inc. | Radially expandable fixation member |
US5156623A (en) | 1990-04-16 | 1992-10-20 | Olympus Optical Co., Ltd. | Sustained release material and method of manufacturing the same |
US5123917A (en) | 1990-04-27 | 1992-06-23 | Lee Peter Y | Expandable intraluminal vascular graft |
US5064435A (en) | 1990-06-28 | 1991-11-12 | Schneider (Usa) Inc. | Self-expanding prosthesis having stable axial length |
US5122154A (en) | 1990-08-15 | 1992-06-16 | Rhodes Valentine J | Endovascular bypass graft |
US5161547A (en) | 1990-11-28 | 1992-11-10 | Numed, Inc. | Method of forming an intravascular radially expandable stent |
US5198308A (en) * | 1990-12-21 | 1993-03-30 | Zimmer, Inc. | Titanium porous surface bonded to a cobalt-based alloy substrate in an orthopaedic implant device |
US5116360A (en) | 1990-12-27 | 1992-05-26 | Corvita Corporation | Mesh composite graft |
US5135536A (en) | 1991-02-05 | 1992-08-04 | Cordis Corporation | Endovascular stent and method |
US5116365A (en) | 1991-02-22 | 1992-05-26 | Cordis Corporation | Stent apparatus and method for making |
US5151105A (en) | 1991-10-07 | 1992-09-29 | Kwan Gett Clifford | Collapsible vessel sleeve implant |
US5358533A (en) * | 1992-02-19 | 1994-10-25 | Joint Medical Products Corporation | Sintered coatings for implantable prostheses |
US5505984A (en) * | 1993-01-21 | 1996-04-09 | England; Garry L. | Method for forming biocompatible components using an isostatic press |
US6774278B1 (en) * | 1995-06-07 | 2004-08-10 | Cook Incorporated | Coated implantable medical device |
CA2178541C (en) * | 1995-06-07 | 2009-11-24 | Neal E. Fearnot | Implantable medical device |
WO1998000574A1 (en) * | 1996-06-28 | 1998-01-08 | Metalplus (Proprietary) Limited | Thermal spraying method and apparatus |
US6099561A (en) * | 1996-10-21 | 2000-08-08 | Inflow Dynamics, Inc. | Vascular and endoluminal stents with improved coatings |
US6143370A (en) * | 1997-08-27 | 2000-11-07 | Northeastern University | Process for producing polymer coatings with various porosities and surface areas |
US6428579B1 (en) * | 1998-07-01 | 2002-08-06 | Brown University Research Foundation | Implantable prosthetic devices coated with bioactive molecules |
JP4091728B2 (en) * | 2000-03-27 | 2008-05-28 | 京セラ株式会社 | Bioimplant material and its manufacturing method |
US6394944B1 (en) * | 2000-05-12 | 2002-05-28 | American Roller Company | Elastomeric covered roller having a thermally sprayed bonding material |
US6444259B1 (en) * | 2001-01-30 | 2002-09-03 | Siemens Westinghouse Power Corporation | Thermal barrier coating applied with cold spray technique |
US20020138136A1 (en) * | 2001-03-23 | 2002-09-26 | Scimed Life Systems, Inc. | Medical device having radio-opacification and barrier layers |
US7201940B1 (en) * | 2001-06-12 | 2007-04-10 | Advanced Cardiovascular Systems, Inc. | Method and apparatus for thermal spray processing of medical devices |
US20040088038A1 (en) * | 2002-10-30 | 2004-05-06 | Houdin Dehnad | Porous metal for drug-loaded stents |
-
2001
- 2001-06-12 US US09/880,514 patent/US7201940B1/en not_active Expired - Lifetime
-
2002
- 2002-12-30 US US10/331,838 patent/US7163715B1/en not_active Expired - Fee Related
-
2006
- 2006-10-17 US US11/582,703 patent/US7514122B2/en not_active Expired - Fee Related
-
2007
- 2007-03-16 US US11/724,766 patent/US20070166496A1/en not_active Abandoned
- 2007-04-05 US US11/784,267 patent/US20070184228A1/en not_active Abandoned
-
2009
- 2009-03-18 US US12/406,866 patent/US7854958B2/en not_active Expired - Fee Related
Patent Citations (102)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3657744A (en) * | 1970-05-08 | 1972-04-25 | Univ Minnesota | Method for fixing prosthetic implants in a living body |
US4140126A (en) * | 1977-02-18 | 1979-02-20 | Choudhury M Hasan | Method for performing aneurysm repair |
US4655771B1 (en) * | 1982-04-30 | 1996-09-10 | Medinvent Ams Sa | Prosthesis comprising an expansible or contractile tubular body |
US4655771A (en) * | 1982-04-30 | 1987-04-07 | Shepherd Patents S.A. | Prosthesis comprising an expansible or contractile tubular body |
US4512338A (en) * | 1983-01-25 | 1985-04-23 | Balko Alexander B | Process for restoring patency to body vessels |
US4503569A (en) * | 1983-03-03 | 1985-03-12 | Dotter Charles T | Transluminally placed expandable graft prosthesis |
US4656083A (en) * | 1983-08-01 | 1987-04-07 | Washington Research Foundation | Plasma gas discharge treatment for improving the biocompatibility of biomaterials |
US5197977A (en) * | 1984-01-30 | 1993-03-30 | Meadox Medicals, Inc. | Drug delivery collagen-impregnated synthetic vascular graft |
US5725672A (en) * | 1984-02-13 | 1998-03-10 | Jet Process Corporation | Apparatus for the high speed, low pressure gas jet deposition of conducting and dielectric thin sold films |
US4633873A (en) * | 1984-04-26 | 1987-01-06 | American Cyanamid Company | Surgical repair mesh |
US4580568A (en) * | 1984-10-01 | 1986-04-08 | Cook, Incorporated | Percutaneous endovascular stent and method for insertion thereof |
US4728328A (en) * | 1984-10-19 | 1988-03-01 | Research Corporation | Cuffed tubular organic prostheses |
US4718907A (en) * | 1985-06-20 | 1988-01-12 | Atrium Medical Corporation | Vascular prosthesis having fluorinated coating with varying F/C ratio |
US4650466A (en) * | 1985-11-01 | 1987-03-17 | Angiobrade Partners | Angioplasty device |
US4739762A (en) * | 1985-11-07 | 1988-04-26 | Expandable Grafts Partnership | Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft |
US5102417A (en) * | 1985-11-07 | 1992-04-07 | Expandable Grafts Partnership | Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft |
US4739762B1 (en) * | 1985-11-07 | 1998-10-27 | Expandable Grafts Partnership | Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft |
US4922905A (en) * | 1985-11-30 | 1990-05-08 | Strecker Ernst P | Dilatation catheter |
US4649922A (en) * | 1986-01-23 | 1987-03-17 | Wiktor Donimik M | Catheter arrangement having a variable diameter tip and spring prosthesis |
US4740207A (en) * | 1986-09-10 | 1988-04-26 | Kreamer Jeffry W | Intralumenal graft |
US4723549A (en) * | 1986-09-18 | 1988-02-09 | Wholey Mark H | Method and apparatus for dilating blood vessels |
US4722335A (en) * | 1986-10-20 | 1988-02-02 | Vilasi Joseph A | Expandable endotracheal tube |
US4893623A (en) * | 1986-12-09 | 1990-01-16 | Advanced Surgical Intervention, Inc. | Method and apparatus for treating hypertrophy of the prostate gland |
US4907336A (en) * | 1987-03-13 | 1990-03-13 | Cook Incorporated | Method of making an endovascular stent and delivery system |
US4800882A (en) * | 1987-03-13 | 1989-01-31 | Cook Incorporated | Endovascular stent and delivery system |
US4816339A (en) * | 1987-04-28 | 1989-03-28 | Baxter International Inc. | Multi-layered poly(tetrafluoroethylene)/elastomer materials useful for in vivo implantation |
US5306286A (en) * | 1987-06-25 | 1994-04-26 | Duke University | Absorbable stent |
US5089005A (en) * | 1987-08-13 | 1992-02-18 | Terumo Kabushiki Kaisha | Catheter for the introduction of an expandable member |
US5192307A (en) * | 1987-12-08 | 1993-03-09 | Wall W Henry | Angioplasty stent |
US6015430A (en) * | 1987-12-08 | 2000-01-18 | Wall; William H. | Expandable stent having a fabric liner |
US4998539A (en) * | 1987-12-18 | 1991-03-12 | Delsanti Gerard L | Method of using removable endo-arterial devices to repair detachments in the arterial walls |
US4892539A (en) * | 1988-02-08 | 1990-01-09 | D-R Medical Systems, Inc. | Vascular graft |
US5192311A (en) * | 1988-04-25 | 1993-03-09 | Angeion Corporation | Medical implant and method of making |
US4986831A (en) * | 1988-04-25 | 1991-01-22 | Angeion Corporation | Medical implant |
US4994298A (en) * | 1988-06-07 | 1991-02-19 | Biogold Inc. | Method of making a biocompatible prosthesis |
US5092877A (en) * | 1988-09-01 | 1992-03-03 | Corvita Corporation | Radially expandable endoprosthesis |
US4981478A (en) * | 1988-09-06 | 1991-01-01 | Advanced Cardiovascular Systems | Composite vascular catheter |
US5176661A (en) * | 1988-09-06 | 1993-01-05 | Advanced Cardiovascular Systems, Inc. | Composite vascular catheter |
US5085629A (en) * | 1988-10-06 | 1992-02-04 | Medical Engineering Corporation | Biodegradable stent |
US4913141A (en) * | 1988-10-25 | 1990-04-03 | Cordis Corporation | Apparatus and method for placement of a stent within a subject vessel |
US5078726A (en) * | 1989-02-01 | 1992-01-07 | Kreamer Jeffry W | Graft stent and method of repairing blood vessels |
US5007926A (en) * | 1989-02-24 | 1991-04-16 | The Trustees Of The University Of Pennsylvania | Expandable transluminally implantable tubular prosthesis |
US5289831A (en) * | 1989-03-09 | 1994-03-01 | Vance Products Incorporated | Surface-treated stent, catheter, cannula, and the like |
US5108755A (en) * | 1989-04-27 | 1992-04-28 | Sri International | Biodegradable composites for internal medical use |
US5100429A (en) * | 1989-04-28 | 1992-03-31 | C. R. Bard, Inc. | Endovascular stent and delivery system |
US4990155A (en) * | 1989-05-19 | 1991-02-05 | Wilkoff Howard M | Surgical stent method and apparatus |
US4994071A (en) * | 1989-05-22 | 1991-02-19 | Cordis Corporation | Bifurcating stent apparatus and method |
US5015253A (en) * | 1989-06-15 | 1991-05-14 | Cordis Corporation | Non-woven endoprosthesis |
US5084065A (en) * | 1989-07-10 | 1992-01-28 | Corvita Corporation | Reinforced graft assembly |
US5002560A (en) * | 1989-09-08 | 1991-03-26 | Advanced Cardiovascular Systems, Inc. | Expandable cage catheter with a rotatable guide |
US5108416A (en) * | 1990-02-13 | 1992-04-28 | C. R. Bard, Inc. | Stent introducer system |
US5107852A (en) * | 1990-04-02 | 1992-04-28 | W. L. Gore & Associates, Inc. | Catheter guidewire device having a covering of fluoropolymer tape |
US5078720A (en) * | 1990-05-02 | 1992-01-07 | American Medical Systems, Inc. | Stent placement instrument and method |
US5078736A (en) * | 1990-05-04 | 1992-01-07 | Interventional Thermodynamics, Inc. | Method and apparatus for maintaining patency in the body passages |
US5290271A (en) * | 1990-05-14 | 1994-03-01 | Jernberg Gary R | Surgical implant and method for controlled release of chemotherapeutic agents |
US5302414A (en) * | 1990-05-19 | 1994-04-12 | Anatoly Nikiforovich Papyrin | Gas-dynamic spraying method for applying a coating |
US5302414B1 (en) * | 1990-05-19 | 1997-02-25 | Anatoly N Papyrin | Gas-dynamic spraying method for applying a coating |
US5279594A (en) * | 1990-05-23 | 1994-01-18 | Jackson Richard R | Intubation devices with local anesthetic effect for medical use |
US5108417A (en) * | 1990-09-14 | 1992-04-28 | Interface Biomedical Laboratories Corp. | Anti-turbulent, anti-thrombogenic intravascular stent |
US5304200A (en) * | 1991-05-29 | 1994-04-19 | Cordis Corporation | Welded radially expandable endoprosthesis and the like |
US5183085A (en) * | 1991-09-27 | 1993-02-02 | Hans Timmermans | Method and apparatus for compressing a stent prior to insertion |
US5282860A (en) * | 1991-10-16 | 1994-02-01 | Olympus Optical Co., Ltd. | Stent tube for medical use |
US5206341A (en) * | 1991-11-21 | 1993-04-27 | Southern Research Institute | Polymers from hydroxy acids and polycarboxylic acids |
US5716406A (en) * | 1991-12-06 | 1998-02-10 | North Shore University Hospital Research Corp. | Method of reducing medical device related infections |
US5192297A (en) * | 1991-12-31 | 1993-03-09 | Medtronic, Inc. | Apparatus and method for placement and implantation of a stent |
US5282823A (en) * | 1992-03-19 | 1994-02-01 | Medtronic, Inc. | Intravascular radially expandable stent |
US5383927A (en) * | 1992-05-07 | 1995-01-24 | Intervascular Inc. | Non-thromogenic vascular prosthesis |
US5290230A (en) * | 1992-05-11 | 1994-03-01 | Advanced Cardiovascular Systems, Inc. | Intraluminal catheter with a composite shaft |
US5624411A (en) * | 1993-04-26 | 1997-04-29 | Medtronic, Inc. | Intravascular stent and method |
US5735892A (en) * | 1993-08-18 | 1998-04-07 | W. L. Gore & Associates, Inc. | Intraluminal stent graft |
US5618298A (en) * | 1993-10-23 | 1997-04-08 | Simon; Michael | Vascular prosthesis made of resorbable material |
US5389106A (en) * | 1993-10-29 | 1995-02-14 | Numed, Inc. | Impermeable expandable intravascular stent |
US5718723A (en) * | 1994-03-15 | 1998-02-17 | Seikagaku Kogyo Kabushiki Kaisha (Seikagaku Corporation) | Artificial blood vessel and process for producing the same |
US6015429A (en) * | 1994-09-08 | 2000-01-18 | Gore Enterprise Holdings, Inc. | Procedures for introducing stents and stent-grafts |
US5707388A (en) * | 1994-12-09 | 1998-01-13 | Intervascular, Inc. | High hoop strength intraluminal stent |
US5869127A (en) * | 1995-02-22 | 1999-02-09 | Boston Scientific Corporation | Method of providing a substrate with a bio-active/biocompatible coating |
US5601593A (en) * | 1995-03-06 | 1997-02-11 | Willy Rusch Ag | Stent for placement in a body tube |
US5601538A (en) * | 1995-03-07 | 1997-02-11 | Medtronic, Inc. | Flow directed catheter with hydrophilic distal end |
US20020032477A1 (en) * | 1995-04-19 | 2002-03-14 | Michael N. Helmus | Drug release coated stent |
US6013100A (en) * | 1995-05-19 | 2000-01-11 | Inoue; Kanji | Appliance to be implanted, method of collapsing the appliance to be implanted and method of using the appliance to be implanted |
US5730733A (en) * | 1995-06-01 | 1998-03-24 | Scimed Life Systems, Inc. | Flow assisted catheter |
US6010530A (en) * | 1995-06-07 | 2000-01-04 | Boston Scientific Technology, Inc. | Self-expanding endoluminal prosthesis |
US5609629A (en) * | 1995-06-07 | 1997-03-11 | Med Institute, Inc. | Coated implantable medical device |
US5718726A (en) * | 1995-09-12 | 1998-02-17 | Biotronik Mess- und Therapiegerate GmbH & Co | Method of attaching heparin to, and immobilizing it on, inorganic substrate surfaces of cardiovascular implants |
US5603991A (en) * | 1995-09-29 | 1997-02-18 | Target Therapeutics, Inc. | Method for coating catheter lumens |
US5607442A (en) * | 1995-11-13 | 1997-03-04 | Isostent, Inc. | Stent with improved radiopacity and appearance characteristics |
US6025034A (en) * | 1995-11-13 | 2000-02-15 | University Of Connecticut And Rutgers | Method of manufacture of nanostructured feeds |
US6027526A (en) * | 1996-04-10 | 2000-02-22 | Advanced Cardiovascular Systems, Inc. | Stent having varied amounts of structural strength along its length |
US20020042645A1 (en) * | 1996-07-03 | 2002-04-11 | Shannon Donald T. | Drug eluting radially expandable tubular stented grafts |
US6184266B1 (en) * | 1996-07-11 | 2001-02-06 | Scimed Life Systems, Inc. | Medical devices comprising cross-linked hydrogels having improved mechanical properties |
US5713949A (en) * | 1996-08-06 | 1998-02-03 | Jayaraman; Swaminathan | Microporous covered stents and method of coating |
US6010529A (en) * | 1996-12-03 | 2000-01-04 | Atrium Medical Corporation | Expandable shielded vessel support |
US5868783A (en) * | 1997-04-16 | 1999-02-09 | Numed, Inc. | Intravascular stent with limited axial shrinkage |
US5741327A (en) * | 1997-05-06 | 1998-04-21 | Global Therapeutics, Inc. | Surgical stent featuring radiopaque markers |
US6174330B1 (en) * | 1997-08-01 | 2001-01-16 | Schneider (Usa) Inc | Bioabsorbable marker having radiopaque constituents |
US6010521A (en) * | 1997-11-25 | 2000-01-04 | Advanced Cardiovasular Systems, Inc. | Catheter member with bondable layer |
US6019789A (en) * | 1998-04-01 | 2000-02-01 | Quanam Medical Corporation | Expandable unit cell and intraluminal stent |
US6168619B1 (en) * | 1998-10-16 | 2001-01-02 | Quanam Medical Corporation | Intravascular stent having a coaxial polymer member and end sleeves |
US6042597A (en) * | 1998-10-23 | 2000-03-28 | Scimed Life Systems, Inc. | Helical stent design |
US6358531B1 (en) * | 1999-02-01 | 2002-03-19 | The Curators Of The University Of Missouri | Method for preparing porous shells or gels from glass particles |
US6368658B1 (en) * | 1999-04-19 | 2002-04-09 | Scimed Life Systems, Inc. | Coating medical devices using air suspension |
US6502767B2 (en) * | 2000-05-03 | 2003-01-07 | Asb Industries | Advanced cold spray system |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080262600A1 (en) * | 1999-03-16 | 2008-10-23 | Jalisi Marc M | Multilayer stent |
US20090299463A1 (en) * | 2001-11-30 | 2009-12-03 | Advanced Cardiovascular Systems, Inc. | Modified Surface For An Implantable Device And A Method Of Producing The Same |
US8123799B1 (en) | 2001-11-30 | 2012-02-28 | Advanced Cardiovascular Systems, Inc. | Modified implantable device surface and a method of making the same |
US8382815B2 (en) | 2001-11-30 | 2013-02-26 | Advanced Cardiovascular Systems, Inc. | TiNxCy modified surface for an implantable device and a method of producing the same |
US8470019B1 (en) | 2001-11-30 | 2013-06-25 | Advanced Cardiovascular Systems, Inc. | TiNxOy modified surface for an implantable device and a method of producing the same |
US8834555B2 (en) | 2001-11-30 | 2014-09-16 | Abbott Cardiovascular Systems Inc. | TiNxCy modified surface for an implantable device and a method of producing the same |
US8864818B2 (en) | 2001-11-30 | 2014-10-21 | Abbott Cardiovascular Systems Inc. | TiNxOy Modified surface for an implantable device and a method of producing the same |
US20140364960A1 (en) * | 2012-01-18 | 2014-12-11 | Meko Laserstrahl-Materialbearbeitungen E.K | Nickel-free iron alloy for stents |
US9555158B2 (en) * | 2012-01-18 | 2017-01-31 | Meko Laserstrahl-Materialbearbeitungen E.K | Nickel-free iron alloy for stents |
Also Published As
Publication number | Publication date |
---|---|
US20070036905A1 (en) | 2007-02-15 |
US7854958B2 (en) | 2010-12-21 |
US7163715B1 (en) | 2007-01-16 |
US7514122B2 (en) | 2009-04-07 |
US7201940B1 (en) | 2007-04-10 |
US20070184228A1 (en) | 2007-08-09 |
US20090176005A1 (en) | 2009-07-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7201940B1 (en) | Method and apparatus for thermal spray processing of medical devices | |
US6725901B1 (en) | Methods of manufacture of fully consolidated or porous medical devices | |
US7344560B2 (en) | Medical devices and methods of making the same | |
EP1866006B1 (en) | Medical devices including composites | |
US9034456B2 (en) | Medical devices and methods of making the same | |
US7604662B2 (en) | Endoprostheses containing boride intermetallic phases | |
US6979346B1 (en) | System and method for improved stent retention | |
US9034245B2 (en) | Method for forming a tubular medical device | |
US20050131522A1 (en) | Medical devices and methods of making the same | |
US20040088038A1 (en) | Porous metal for drug-loaded stents | |
US20120265291A1 (en) | Manufacture of fine-grained material for use in medical devices | |
JP2008515563A6 (en) | Medical device and manufacturing method thereof | |
WO2009079282A1 (en) | A method for forming a tubular medical device | |
US7972375B2 (en) | Endoprostheses including metal matrix composite structures | |
WO2023048840A1 (en) | Coating for refractory metal alloy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |